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The long QT syndrome (LQTS), which is characterized as prolongation of QT intervals, is an 
inherited and acquired channelopathy associated with sudden cardiac death due to ventricular 
arrhythmias. Malfunction of human ether-á-go-go-related gene (HERG) encoded K+ channel 
is one of the major causes of LQTS. In the first chapter of this thesis, the physiology of 
HERG channel including the structure, unique gating and biosynthesis, was reviewed. Then, 
recent progress on regulatory effects of sex hormones on HERG current was summarized.  
Proarrhythmic drugs induce torsade de pointes more frequently in women than men. To 
reveal the mechanism for the gender differences in QT interval and acquired LQTS, I first 
investigated the effect of androgen and estrogen on HERG proteins. It was found that 
treatment with estrogen failed to affect HERG channel expression. In contrast, androgens 
increased HERG protein abundance in the presence of cardiac androgen receptor variant 
(AR45), but not full length androgen receptor. Confocal microscopy showed that the 
upregulated HERG proteins were seen in the ER, Golgi complex and plasma membrane 
without clear preferential colocalization. Chronic androgen treatment also increased HERG 
K+ current density in the presence of AR45. Moreover, 5α-DHT increased ERG protein 
abundance in isolated rabbit cardiac myocytes. The upregulation of HERG protein was due to 
inhibition of channel degradation, instead of enhancing channel synthesis. In addition, 5α-
DHT/AR45 signaling induced phosphorylation of extracellular signaling regulated kinase 
(ERK1/2).  Blockade of ERK1/2 prevented the effect of androgen on HERG protein 
abundance. In conclusion, these data provide evidence that stimulation of AR45 receptors by 
androgens upregulates HERG K+ channel abundance and activity mainly through stabilizing 
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HERG protein in an ERK1/2 dependent mechanism and suggest a mechanism to explain the 
sex difference in the long QT syndrome. 
Progesterone level increases steadily during pregnancy, and reaches μmol/L level before the 
delivery. The second part of my work was to investigate the effect of progesterone on HERG 
channel function. It was found that chronic progesterone treatment decreased the abundance 
of mature HERG channel in rat neonatal cardiac myocytes and HERG-HEK293 cells. 
Progesterone also concentration-dependently decreased HERG current density. 
Immunofluoresence microscopy shows that progesterone preferentially decreased HERG 
channel protein abundance in the plasma membrane, induced protein accumulation in the 
dilated ER. Application of sterol binding agent or over-expression of Rab9 rescued the 
progesterone-induced HERG trafficking defect. Disturbance of intracellular cholesterol 
homeostasis mimicked the effect of progesterone on HERG channel trafficking. Progesterone 
may impair HERG channel folding in the ER and/or block its trafficking to the Golgi 
complex by disrupting intracellular cholesterol homeostasis. This finding may reveal a novel 
molecular mechanism to explain the QT prolongation during late pregnancy. 
In conclusion, this thesis examined how sex hormones regulate HERG K+ channels with a 
combination of pharmacological manipulations, confocal microscopy, molecular biology and 
electrical physiology. This study not only provides a molecular mechanism for the sex 
differences in QT intervals and drug-induced arrhythmias but also explains the longer QT 
interval during late pregnancy and the high risk of arrhythmias development in the fetus.  
 
 
Chapter 1 INTRODUCTION AND LITERATURE REVIEW 
 
Sudden cardiac death causes approximately half of all cardiovascular related deaths, which 
account for more than 300,000 deaths every year in the United States alone1-2. Sudden 
cardiac death is an unexpected death which happens within one hour from the onset of the 
cardiac event. Although some cases are results of previous cardiac pathology, many victims 
are otherwise healthy with no heart disease history and free from heart structure damage. 
This indicates that the abnormities of cardiac electrical transmission, such as prolonged QT 
intervals and slower heart rates, may be the cause of some sudden cardiac deaths. 
The long QT syndrome (LQTS), which is characterized as prolongation of QT intervals, is an 
inherited and acquired channelopathy associated with sudden cardiac death due to ventricular 
arrhythmias. These arrhythmias cause loss of cardiac pump function, and then cut off blood 
supply to the brain, thus inducing brain death. For this reason, LQTS is potentially fatal and 
high mortality is noticed. The initial recorded mortality rate is extremely high due to the poor 
diagnosis in the early years, as only the most severely affected patients can be identified. 
More recently, the mortality of untreated symptomatic patients was first reported to be 71 %, 
but later dropped to 20 % for patients treated with beta blocker. The inherited LQTS can be 
divided into several subgroups based on the type of affected molecules which are listed in the 
table (1-1). 
Overall, the first three kinds of LQTS (LQT1, 2 and 3) are common, and present in more than 
90% of inherited LQTS patients. Acquired LQTS is another form of LQTS, which is more 
likely related to the blockage of rapidly activating delayed rectifier K+ current (Ikr), whose 
alpha-subunit is encoded by human ether-a-go-go related gene (HERG). 
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Table 1-1 The Genes associated with inherited Long QT Syndromes 
Type Gene Chromosomal 
localization 







LQT1 KCNQ1 11p15.5 Kv7.1/KvLQT1 α-subunit IKs Lose 40–55 
LQT2 KCNH2 7q35–7q36 Kv11.1/HERG α-subunit IKr Lose 35–45 
LQT3 SCN5A 3p21 Nav1.5 α-subunit INa Gain 2–8 
LQT4 ANK2 4q25–4q27 Ankyrin B Adaptor (INa-K, 
INa-Ca, INa) 
Lose <1 
LQT5 KCNE1 21p22 minK β-subunit IKs Lose <1 
LQT6 KCNE2 21p22 MiRP1 β-subunit IKr Lose <1 
LQT7 KCNJ2 17q23.1–
17q24 
Kir2.1 α-subunit IK1 Lose <1 
LQT8 CACNA1C 12p13.3 Cav1.2  α-subunit ICa Gain <1 
LQT9 CAV3 3p25 M-Caveolin Adaptor (INa) Lose <1 
LQT10 SCN4B 11q23 Navb4 β-subunit INa Lose <0.1 
LQT11 AKAP9 7q21–7q22 Yotiao Adaptor(IKs) Lose <0.1 
LQT12 SNTA1 20q11.2 a1-Syntrophin Scaffolding 
protein (INa) 
Lose <0.1 
The table is reproduced and adopted from Hedley et al., 20093.  
HERG encoded potassium channel has been extensively studied, not only because it is the 
first reported gene for cardiac disease, but also because it affects a large number of LQTS 
patients (around 40% of inherited LQTS patients and a majority of acquired LQTS patients). 
Next we will discuss the structure, function, and biosynthesis of HERG. 
1.1 HERG gene and protein structure  
The HERG gene was initially isolated by screening a human hippocampal cDNA library with 
probes based on mouse eag4. HERG gene is located on the chromosome 7 (7q35-36)5, and 
the mRNA is 3900 bp long which contains 16 exons and polyA signal (NCBI Reference 
Sequence: NM_000238.2). According to the website http://www.fsm.it/cardmoc/, 291 HERG 
mutations have been reported by now. The mutation types include missense, nonsense, 
deletion, insertion, splice error, frameshift, deletion/frameshift, duplication/inframe, 
duplication/frameshift, insertion/frameshift. These mutations can cause loss-of-function via 
affecting HERG channel transcription, translation, trafficking, or channel gating.  
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HERG encodes a polypeptide with a predicted molecular weight of 127 kDa, which appeared 
on western blot as bands of 135 kDa and 155 kDa because of the posttranslational 
modifications (such as glycosylation). The membrane topology of HERG is predicted based 
on the knowledge of HERG sequence and other ion channel structures (Figure 1-1). HERG 
potassium channels are transmembrane proteins which contain intracellular N-terminal 
domain, six transmembrane domains (denoted S1-S6), pore loop, S5-P linker (between 
domain S5 and pore loop) and C-terminal domain. N-terminal domain is crucial for channel 
deactivation. S4 domain contains multiple positive charges and is the major part of the 
voltage sensor. The pore loop contains potassium ion selectivity filter (GYG) and 
glycosylation site (N598). C-terminal domain contains several phosphorylation sites and 
trafficking signals. 





















Figure 1-1 Topology of HERG protein 
1.2 HERG channel gating 
Voltage gated potassium (Kv) channels generally have at least three conformation states: 
closed, open, and inactivated. Among these states, only the open state is conducting state. 
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Transition from the closed states to the open states is called activation, and the reverse 
transition called deactivation. Both processes rely on the conformation changes of 
transmembrane domain S6. Inactivation of HERG channel relies on the conformation 
changes around the selectivity filter6. The general gating sequence of a Kv channel is a fast 
activation, slow and voltage-independent inactivation, and slow deactivation. Despite the 
high homology in amino acid sequence to other voltage-gated potassium channels, HERG 
channel has unique current kinetics: slower onset of the activation and fast and voltage-
dependent of the inactivation. This unique gating is crucial as it can suppress the propagation 
of the premature beats and prevent arrhythmias triggered by premature beats (Lu et al., 2001).  
The mutagenesis studies on HERG channels, either naturally occurring or artificially 





Figure 1-1 HERG gating 
1.2.1 Activation 
The activation gate of potassium channel is formed by the C-terminal part of the S6 
transmembrane helices. These helices form a bundle crossing and prevent potassium ions 
going through12. The gating hinge in HERG channel is formed by 655PVG657 instead of the 
conserved PVP motif in Kv1-Kv4 channels 8, 13. This is supported by the experiment that 
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replacement of glycine with proline at the position 657 results in a permanently open 
channel8.   
For voltage-gated ion channels, S1-S4 voltage sensor can modulate the transition between the 
closed state and the open state. In HERG channel, the six basic amino acids located in the S4 
domain provide positive charges needed for the detection of transmembrane voltage changes. 
On the other hand, the salt bridges formed between these basic amino acids and acidic amino 
acids in S1-S3 domains can stabilize the voltage sensor in either open or closed state 14.  
Mutations occurred in or close to the voltage sensor may affect its conformation and change 
HERG channel activation9, 11.  
The molecular basis for the slow onset of activation for HERG channel is not well 
understood. Studies on the gating currents and fluorescence labeling indicate that the slow 
voltage sensor movement may contribute to the slow activation of HERG channels15-16.  
1.2.2 Deactivation 
The deactivation of HERG channel is mainly regulated by its N-terminal region. Mutations 
(missense or deletion) in the N-terminal of HERG channel can accelerate channel 
deactivation, and applying of recombinant N-terminal domain can restore the deactivation7, 17. 
1.2.3 Inactivation 
There are two main theories explain the inactivation of voltage-gated potassium channels: N-
type inactivation (ball and chain model) and C-type inactivation (collapse of the pore model). 




 Several studies on the voltage dependency of HERG inactivation indicate that this voltage 
sensitivity is not from the voltage sensor of activation. Firstly, mutations in the S5-P linker 
and pore loop affect inactivation but not activation 18-21. These data indicate that S5-P linker 
and pore loop are important for the voltage-dependency of HERG inactivation. Secondly, 
changes of temperature have opposite effects on activation and inactivation of HERG 
channel22. 
1.2.4 Conductance/ionic selectivity  
The ionic selectivity and channel conductance of HERG channel are mainly determined by 
the pore loop, especially the selectivity filter. Mutations in this area can change ionic 
selectivity and channel conductance, if the mutant channels can be inserted into the plasma 
membrane properly 23-26. However, the mutations in this area affect HERG channel proper 
folding and most likely induce trafficking defect 27. 
1.3 Modulation of HERG channel gating 
The gating of HERG channel can be regulated by the surrounding environment (ions, 
proteins, and lipids), applied chemicals (blockers and activators), temperature, and 
modification on the channel (as by protein kinases). 
1.3.1 Extracellular ions 
K+: Extracellular potassium ions are important for HERG channel function. Potassium ion 
free solution is an extreme situation, on which HERG channels will go into an unusual non-
conductance state within minutes28. This process is reversible and linked with the pore region 
of HERG channel, but different from that of inactivation or channel blocker E-4031 binding 
sites28. On the other hand, elevation of extracellular potassium ion concentration has no 
significant effect on the gating of  HERG channel29. 
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Ca2+/Mg2+: Increasing extracellular Ca2+ causes a reduction of HERG currents via 
depolarizing shifting of voltage dependency of activation, slowing of activation, and 
accelerating of deactivation 30-31. The extracellular Mg2+ has similar effect as Ca2+ 30, 32. 
pH: Extracellular pH may affect the charges of amino acids in HERG channel, which in turn 
affect HERG gating. Extracellular acidification suppresses HERG current via depolarizing 
shifting of the voltage-dependence of the activation and acceleration of deactivation29, 33-35. 
1.3.2 Blockers and activators 
Blockers: Drug blockage on HERG channel is a main cause for drug-induced LQTS, and 
several drugs as astemizole, probucol and terfenadine have been removed from market 
because of their high potency of blocking HERG channel. A detailed list of drugs related 
with LQTS is compiled in a website: http://www.azcert.org/medical-pros/drug-lists/drug-
lists.cfm.  
Great efforts have been made to study the molecular basis of drug blockage on HERG 
channel, and the knowledge gained has been applied to the safety of new drug development.  
It is well accepted that aromatic amino acids tyrosine652 and phenylalanine656 which face 
the inner cavity, are high affinity binding sites for most drugs36. However, the bindings 
between the channel and drugs are far more complex as the precise binding arrangements 
require residues within and between different subunits, and the arrangements are likely to 
change during the process of gating. It is suggested that the inactivated state is the most 
accessible state for high-affinity binding drugs (reviewed in Perrin et al., 200837). 
Activators: A group of HERG channel activators that can potentiate HERG current have 
been discovered recently. These activators can increase HERG currents via reduction of 
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HERG inactivation (ICA-10557438), slowing of HERG deactivation (RPR26024339), 
facilitation of activation, or the combinations of these effects (PD-30724340; A-93514241). 
The molecular basis for the HERG activator is not clear, although S5-P linker and pore loop 
are reported to be the binding site for HERG channel activator40. 
1.3.3 Lipids 
In the plasma membrane, HERG channels are concentrated in the cholesterol and 
sphingolipid enriched domains42. As floating in the membrane lipid “ocean”, the function of 
HERG channel can be modulated by surrounding lipids easily. 
Cholesterol is a major component of plasma membrane, and it was found that both depletion 
and enrichment of membrane cholesterol can affect HERG K+ current. Depletion of 
membrane cholesterol via sterol binding agent cyclodextrin can shift voltage dependency of 
activation and deactivation of HERG currents42. Enrichment of membrane cholesterol 
decreases HERG current amplitude43.  
Phosphatidyl inositol bisphosphate (PIP2) is another important lipid which can be modulated 
during autonomic stimulation. PIP2 can increase HERG current amplitude and 
hyperpolarizing shift the voltage dependency of activation, accelerate activation and 
decelerate inactivation44. The binding sites for PIP2 are suggested to be located at the C-
terminal region of HERG channel (amino acids 883-894) where has higher concentration of 
positively charged amino acids 45.  
Other lipids also affect HERG channel function. Ceramide, a sphingolipid formed during 
cellular stresses, can reversibly inhibit HERG currents, shift voltage dependency of 
activation, and accelerate deactivation, probably via facilitation of HERG channel 
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translocation into lipid raft46. Phospholipid metabolite 1-palmitoyl-lysophosphatidylcholine, 
which accumulated in the ischemia heart, can enhance HERG currents via affecting 
activation and inactivation47. Polyunsaturated fatty acids can induce a use-dependent 
inhibition of HERG channels with changes on channel activation and inactivation 48. 
1.3.4 Potential Interaction Proteins 
HERG protein is the pore-forming subunit for Ikr, and the accessory subunit is not clear yet. 
Several proteins were reported to have the ability to bind HERG channel and modulate 
HERG K+ currents. 
Mink: Mink was first reported to be associated with KCNQ1 to produce Iks49. Later 
McDonald and colleagues demonstrated that mink can bind HERG protein to form stable 
complex, and decrease current amplitude with unknown mechanism50. 
MinK-related peptide 1 (MiRP1): It is suggested that MiRP1 which modulates HERG 
channel gating and pharmacological characterization is a beta subunit of Ikr51. The authors 
demonstrated that MiRP1 can form stable MiRP1/HERG complex, and the recording currents 
showed decreased peak current amplitude, depolarizing shift of activation and acceleration of 
deactivation, in the Xenopus oocytes expression system. However, later in mammalian 
expression system, Weerapura and colleagues demonstrated that MiRP1 may not be an 
essential part for HERG protein to form Ikr52. 
14-3-3ε:  Kagan and colleagues demonstrated that 14-3-3ε can bind HERG channels which 
are phosphorylated by PKA, and accelerate HERG current kinectics53. 
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1.3.5 Phosphorylation by Protein kinases 
Phosphorylation on HERG protein by protein kinases can introduce negative charges into 
channel domain and affect HERG K+ channel gating. Based on computational prediction and 
mutagenesis studies, the phosphorylation sites of protein kinase A (PKA), protein kinase C 
(PKC) and tyrosine kinase in HERG protein have been uncovered 54-56. 
PKA: Activation of PKA can reduce HERG K+ current amplitude, depolarizing shift voltage 
dependency of activation, accelerate deactivation 56-57. This modulation relies on direct 
phosphorylation on HERG protein as the deletion of four potential phosphorylation sites (one 
located in the N-terminal region and three in the C-terminal region) abolishes this effect56. 
PKC: Pioneered studies on the effect of PKC on HERG channel came from the studies on 
Phorbol 12-myristate 13-acetate (PMA), a classical but non-specific PKC activator. PMA can 
reduce HERG current amplitude and change HERG channel gating significantly: deceleration 
of activation, acceleration of deactivation, depolarizing shift of voltage dependency of 
activation 58. However, Kiehn and colleagues demonstrated that the modulation effect of 
PMA is via PKA59. In another study, Cockerill and colleagues reported that direct activation 
of PKC via 1-stearoyl-2-arachidonyl-glycerol can reduce HERG current amplitude but has no 
changes on HERG gating60. The authors also demonstrated that this modulation relies on the 
direct phosphorylation on HERG protein within N-terminal region. The discrepancy of these 
experiments may result from the cross-talk between different protein kinase systems. 
Tyrosine kinase: Activating Src tyrosine kinase can increase ERG current amplitude, shift 
voltage dependency of activation, and decelerate deactivation61. Inhibition of tyrosine kinase 
via inhibitors or inhibiting peptide can decrease ERG current amplitude 54, 61. The modulation 
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of tyrosine kinase can be significantly attenuated in HERG mutants Y475A and Y611A, 
indicates that Y475 and Y611 are the direct phosphorylation sites for this effect 54.  
1.3.6 Temperature 
Temperature can affect both the voltage-dependency and the rate of HERG channel gating. 
Higher temperature can induce hyperpolarizing shift in the voltage dependency of activation 
and depolarizing shift in the voltage dependency of inactivation22. Higher temperature can 
also accelerate activation, deactivation and inactivation 22, 62.  
1.4 HERG gene transcription and translation 
The transcription of HERG gene is tissue specific.  In rat, erg mRNA is abundant in the heart, 
brain, retina, thymus, and adrenal gland, and is low in skeletal muscle, lung and cornea63. 
The erg mRNA is expressed abundantly and uniformly throughout the heart in human, guinea 
pig, rabbit, dog and rat63.  
The transcription of HERG gene is also developmentally regulated. The detailed information 
of this process is mainly from mouse. Maternal ERG mRNA can be detected from oocyte to 
2-cell stage. Then ERG mRNA level drops till the 8-cell stage, and rises again in the morula. 
During this period, the transcription is uneven as inner cell mass cells have higher 
transcription levels than trophoblast64. The expression of ERG proteins throughout 
preimplantation seems playing a role in controlling the timing of embryo development 65. 
From embryonic day 9.5 (E9.5), mouse ERG mRNA can be detected in the heart and the 
central nervous system (CNS). Later in E13.5, ERG mRNA can also be detected in the 
peripheral nervous systems, the retina, skeletal muscles, gonads and gut. In the adult mouse, 
ERG is expressed in the heart, CNS, retina and dorsal root ganglia 66. Similarly, the 
transcription of ERG in the skeletal muscles and dorsal root ganglia is limited to the 
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embryonic phase of development in quail.  However, the molecular mechanism of these 
developmental changes of ERG transcription, especially the transient transcription in certain 
organs, is not clear. 
The transcription of ERG can also be up-regulated in cancer cells and tumors 67-70 . Lin and 
colleagues studied the upstream of the transcription start site and found several binding sites 
for oncogenes and tumor suppressor genes. This study indicates that the transcription of 
HERG channel may be modulated by oncogenes/tumor suppressor genes, which may explain 
the unusual expression of HERG channels in tumors but not normal original tissues69. 
The transcription and translation of HERG can also be affected in certain pathological 
situations. For example, persistent atrial fibrillation can decrease the mRNA levels of several 
potassium channels including HERG channel71. Hypoxia can enhance the production of 
reactive oxygen species in the mitochondria, which decreases HERG translation and current 
density72.  
Around 25% of reported HERG mutations have premature termination codons 
(http://www.fsm.it/cardmoc/). Such mutation would give truncated proteins if translated 
successfully. However, cells have developed nonsense-mediated mRNA decay (NMD) to 
eliminate the mRNA with premature termination codons. The mRNAs of HERG mutants 
with premature termination codons, as Q1070X, R1014X and W1001X, can be destroyed by 
NMD 73-74. However, it is not clear whether this can be applied to all HERG mutants with 
premature termination codons. 
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MicroRNA (miRNA) mediated mRNA silencing is another mechanism to modulate mRNA 
levels. Xiao and colleagues demonstrated that the up-regulation of miRNA-133 in diabetic 
patient hearts can decrease HERG current via miRNA mediated mRNA silencing75. 
HERG channel translation can be up-regulated via direct phosphorylation on HERG proteins 
by protein kinase A76. The authors suggest that the phosphorylation of the core-glycosylated 
form of HERG protein may promote channel folding, and facilitate the whole process of 
protein translation.  
1.5 HERG Channel Assembly 
HERG channel consists of four subunits, and the assembly occurred in the ER77. In Shaker 
Kv channels, homo-oligomerization is facilitated by the association of homologous 
tetramerizing interaction domains78. However, similar domain is not found in HERG channel 
yet. Some reports demonstrated that the N-terminal region of HERG protein is important for 
channel assembly 77, 79.While other reports show that N-terminal truncations of HERG that 
lack this domain have the ability to form functional channels 20, 80, which indicates that the 
assembly signal is not located in this region.  
On the other hand, Janke and colleagues reported that tetramerizing coiled-coil domain 
located in HERG C-terminal regions is involved in channel assembly81. This is also 
supported by the observations that HERG mutants Q725X and p.R744fs failed in oligomeric 
assembly82-83. 
1.6 HERG trafficking (forward trafficking) 
The trafficking of HERG channel is tightly controlled to ensure insertion of properly folded 
and assembled channels into the plasma membrane. Several factors related to HERG 
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trafficking have been identified, which include glycosylation, ER retention signal and ER 
exit signal, molecular chaperones and small GTPases. 
1.6.1 Glycosylation 
There are two crucial steps for the glycosylation of HERG channel protein. In the ER, high-
mannose oligosaccharides are added onto newly synthesized HERG channel and the 
molecular weight increased from 132 kDa to 135 kDa, as revealed by the treatment of 
PNGase which can cleave asparagine-linked (N-linked) oligosaccharides from glycoproteins 
84. Other modifications may also occurred in the ER as the size of the deglycosylated HERG 
is still larger than predicted value 128 kDa from the mRNA sequence.  In the Golgi complex, 
HERG channels undergo further glycosylation process and then translocate into the plasma 
membrane. The size of the fully glycosylated form of HERG channel protein is about 155 
kDa. As this high molecular weight band represents channels  located in the Golgi complex 
and plasma membrane, the density of this band on the Western blot gel is widely used as an 
important parameter to study HERG channel trafficking. There are two N-linked 
glycosylation consensus sites (N-X-T/S) in the extracellular S5-S6 linker (N598 and N628)85. 
Only N598 is demonstrated to be the site of core-glycosylation23. The non-glycosylatable 
mutant HERG N598Q channel can traffic normally and produce similar currents as WT 
channel23. This data indicate that glycosylation process itself may not be a crucial step to 
control the assembly and trafficking of HERG channel. 
1.6.2 ER retention signal and ER exit signal 
There are several quality control mechanisms in the ER to prevent misfolded and incomplete 
assembled proteins exit the ER which will affect normal cell function seriously.  One 
mechanism is that the proper folding of protein can mask ER retention signal and exposure 
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ER exit signal, which in turn trigger the ER exit. For HERG channel, there is a putative ER 
retention signal in the C-terminus (1005 RGR1007)86. Under normal situation, the C-terminal 
region can mask this ER retention signal once the protein is properly folded86.  
1.6.3 Molecular Chaperones 
Another quality control mechanism is via molecular chaperones. Cytosolic chaperones, heat 
shock protein (hsp) 70 and hsp 90, can bind the newly-synthesized form of HERG channel 
and form a transient complex87. Hsp 70 can hold the newly-synthesized chain and prevent 
intramolecular misfolding/aggregation88 and hsp90 can bind protein to form complex and 
facilitate channel folding89. It is suggested that the formation of transient HERG-hsp70-hsp90 
complex is required for proper folding of HERG channel in the ER90, and the dissociation of 
this complex is important for channel ER exit87. However the exact molecular mechanism for 
the formation and modulation of this complex is unknown.  
ER chaperone protein calnexin can bind immature HERG protein, and this binding requires 
N-linked glycosyation 84. It is suggested that this transient binding may modulate HERG 
channel trafficking. 
Hsp40 type 1 chaperones DJA1 (DNAJA1/Hdj2) and DJA2 (DNAJA2) can also affect 
HERG trafficking via modulate the association of HERG channel and chaperone Heat-shock 
cognate protein 70 (hsc70), which can go proper folding with hsp90 and Hop and FKBP38, 
or go degradation way91-92.  
1.6.4 Small GTPase 
Movement of proteins between different membrane-bound cellular organelles, such as the ER, 
the Golgi complex, and the plasma membrane, is regulated by small GTPase. Newly 
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synthesized proteins can be exported from the ER via COPI or COPII vesicles, which can be 
regulated by GTPase ARF1 and Sar1 respectively. Delisle and colleagues demonstrated that 
the impairment of Sar1 but not ARF1 can dramatically block HERG channel trafficking93. 
On the other hand, impairment of small GTPase Rab11B, which regulates the endosomal 
recycling, also blocks HERG channel trafficking significantly93. Taken together, these data 
indicate that HERG channel may export from the ER via COPII vesicles and endosomal 
recycling prior to being processed in the Golgi complex. 
1.7 Defected HERG channel trafficking 
Recent data indicate that the defected trafficking of HERG channels caused either by HERG 
gene mutations or by drugs can significantly affect HERG function and cause LQTS. The 
studies carried on the mechanisms of HERG trafficking defect and the restoration of normal 
trafficking will be beneficial for therapeutic purpose. 
1.7.1 The mechanisms of HERG trafficking defects 
HERG mutations induced ER retention: Protein trafficking defects are the most common 
mechanism for LQT2 HERG mutations 27, 37. The mutation sites in these trafficking defected 
HERG genes are mainly located in putative alpha-helical or beta-sheet domains, which 
including Per-ARNT-Sim (PAS) domain, transmembrane domain, S5-P linker, pore loop and 
cyclic nucleotide binding domain (cNBD) 27, 37. On the other hand, the mutants out of these 
domains are not likely to cause trafficking defect. Taken together, these data further 
emphasize that the proper folding of HERG channel is crucial for its normal trafficking. 
However, how cells detect the misfolding of HERG channel is not clear. There is one report 
showing that the interactions between the mutant HERG channel and hsp70/hsp90 are 
prolonged compared with the WT HERG channel90. This prolonged association has been 
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interpreted as the attempt to hold the misfolded mutant HERG protein in the ER by hsp70, 
and re-fold them into correct conformation by hsp90. Another report also indicates that the 
binding between the channel and chaperone molecule calnexin is prolonged for HERG 
mutant N470D compared with WT HERG 84. The mutations located in the PAS domain and 
cNBD domain (exposed to the cytosol) may directly interfere the binding with cytosol 
molecular chaperones as hsp70 and hsp90.  
In heterozygous patients, the trafficking defected HERG mutants may also affect WT HERG 
channel trafficking. It is reported that the trafficking defect HERG A651V assembled with 
WT HERG protein and retained most heterotetrameric channels in the ER94.  
HERG mutants affect the interaction between HERG channel and GM130 in the Golgi 
complex. The physiological role for the interaction between HERG channel and GM130 is 
not clear. However, HERG mutants (S818P, V822M and R823W) located in the cNBD 
domain can disrupt the interaction between HERG protein and GM130 by a yeast two-hybrid 
assay95. This disruption may block the intra-Golgi trafficking of mutant proteins. However, 
more studies are needed to clarify the molecular mechanism and the physiological role of this 
binding. 
Drug induced trafficking defect 
Drug induced HERG trafficking defect is a new mechanism for the acquired LQTS. 
Surprisingly, almost 40% of HERG channel blockers have the ability to induce HERG 
trafficking defect 96. Further, drugs which do not block HERG channel also impair channel 
trafficking96 . Despite the number of the drugs impair HERG trafficking, less is known about 
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the molecular mechanism except two groups of drugs: hsp90 inhibitors and Na+/K+ ATPase 
blockers. 
Hsp90 inhibitors: As mentioned previously, hsp90 is an important cytosolic chaperone 
assisting HERG channel folding in the ER. It is no doubt that the inhibition of hsp90 function 
may affect the maturation of HERG channel and promote channel degradation in the ER 87. 
Further, Ficker and colleagues suggested that not only specific hsp90 inhibitors, but also 
other cardiotoxic compounds such as arsenic trioxide and potassium antimony(III) tartrate 
may impair HERG channel trafficking via the inhibition of hsp90 function 97.  
Na+/K+ ATPase blockers: It is well known that Na+/K+ ATPase plays important roles in 
maintaining the Na+/K+ gradient crossing the plasma membrane. Recent studies show that the 
depletion of intracellular K+ by the blocking of Na+/K+ ATPase may impair the folding of 
HERG protein in the ER, which retains the impaired channel in the ER 98-99.  
1.7.2 Restoration of normal HERG trafficking 
The studies on the restoration of normal HERG trafficking may uncover new therapeutic 
applications for LQTS patients. Till now there are three ways to restore normal HERG 
trafficking: Lowing the temperature, non-specific chemical chaperones and specific 
pharmacological chaperones. Anderson and colleagues reported that 19 out of 28 (68%) 
HERG trafficking defect mutants can be rescued and different mutants can be rescued with 
different conditions27. 
Lowing the temperature: Culture temperature is very important for HERG channel 
trafficking. Chen and colleagues demonstrated that the temperature between 27 and 30 
degree is the optimum condition for WT HERG channel trafficking in CHO cells100. 
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Decreasing culture temperature can successfully restore the majority of HERG trafficking 
defects caused by HERG mutations27 or drugs 99. This restoration can be verified by 
recording HERG currents via patch clamp recording, or by detecting fully-glycosylated form 
of HERG protein on Western blot gel, or by immunostaining. There are three possible 
mechanisms for the effect of temperature on HERG trafficking. The first mechanism is that 
lower temperature can prolong the interaction between the HERG channel and chaperones, 
and increase the chance of obtaining the proper folding conformation. The second 
mechanism is that less HERG proteins will be degraded at lower temperature, and more 
HERG channels can reach the plasma membrane. The third mechanism is that at normal 
culturing temperature of 37 degree, the majority of HERG protein may be rapidly 
internalized after inserted into the plasma membrane. Lower temperature can reduce this 
process and more functional channels can stay longer on the plasma membrane100.  
Non-specific chemical chaperones: Small molecule chemical chaperones such as glycerol 
and DMSO are believed have the ability to stabilize protein conformation during the 
maturation process101. Glycerol can rescue trafficking defect mutant HERG N470D 102. 
However, the super high concentrations needed for chemical chaperones to restore HERG 
protein trafficking strongly restrict their clinical use. 
Thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, can 
rescue HERG trafficking defect induced by gene mutation 27, 103. However this effect is not 
likely via the inhibition of SERCA function as other SERCA inhibitors DBHQ and 
cyclopiazonic acid failed to rescue HERG trafficking defect. The mechanism is still unknown. 
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Specific pharmacological chaperones: HERG channel blockers can rescue most HERG 
trafficking defects caused by mutations27, and the efficacy for channel rescue is directly 
linked to the potency of channel blocking 104. It is suggested that HERG channel blockers can 
bind and stabilize channels, which in turn facilitates the trafficking of mutated channels 104. 
 Interestingly, pharmacological chaperones can also restore drug induced HERG trafficking 
defect. For example, HERG channel blocker atemizole can restore the trafficking impaired 
by cardiac glycosides, probably via stabilize the affected HERG channel98.  
1.8 Endocytosis (backward trafficking) 
The density of proteins in the plasma membrane is dependent on the equilibrium between 
exocytosis (forward trafficking) and endocytosis (backward trafficking). However, the 
studies on the backward trafficking of HERG channels are rare. The available data indicate 
that the internalized HERG channels can either enter endosomes and recycle back to the 
plasma membrane, or fuse into lysosomes for degradation.  Diacylglycerol can trigger protein 
kinase C evoked endocytosis of HERG channels105. These internalized HERG channels are 
located in the early endosomes but not lysosomes. On the other hand, lower extracellular 
potassium or ceramide can accelerate HERG channel internalization and the affected HERG 
channels can be infused into lysosome 106-107. 
1.9 HERG channel degradation 
WT HERG channels have a half life time around 8-12 hours, and mutant HERG channels 
have a short life time84 107. The life time of HERG channel protein is mainly determined by 
protein degradation, either proteasomal degradation or lysosomal degradation.  
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The proteasome degradation usually works on the newly synthesized HERG proteins which 
failed in passing the quality check in the ER. Trimming of mannose and adding polyubiquitin 
onto the core-glycosylated HERG channel are necessary for proteasomal degradation of 
HERG proteins 91, 108. Polyubiquitination of HERG protein needs E3 ubiquitin ligase, C-
terminus of Hsc70-interacting protein91. However, the mechanism on the detecting and 
marking misfolded HERG channel for proteasomal degradation is not clear.  
On the other hand, lysosomal degradation can work on the plasma membrane HERG proteins 
which are internalized into endosomes and fused into lysosome later. The knowledge on the 
lysosomal degradation of HERG channel during normal situation is lacking. The only 
information is from the studies on the enhancement of lysosome degradation of HERG 
channels induced by ceramide and depletion of extracellular potassium 28, 106-107, 109.  The 
internalized HERG channels traffic from endosomes to multivesicular bodies and finally 
lysosomes. Monoubquitination but not polyubiquitination, is the sorting signal for the 
lysosome degradation of HERG channels. 
1.10 Current progress on the modulation of sex hormones on HERG K+ 
channels 
Sex hormones include androgen, estrogen and progesterone. Androgen level is high in male 
and considered as “male sex hormone”. Estrogen and progesterone levels are high in female 
and considered as “female sex hormones”. Sex hormones have a steroid nucleus composed of 
four fused rings. All of these hormones can enter the cells easily, bind a variety of targets, 
and execute multiple physiological functions. Heart is one of the target organs for sex 
hormones and increasing data reveal the impacts of gender and sex hormones on human 
cardiac rhythm and arrhythmias. For example, Proarrhythmic drugs induce torsades de 
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pointes (TdP) arrhythmia more frequently in women than men110; women have longer heart 
rate-corrected QT intervals than men110; QTc intervals of males shorten after puberty110. It is 
believed that sex hormones are involved in these gender and development-related changes 
and great efforts have been put to study the effects of sex hormones on cardiac ion channels.  
Sex hormones as estrogen and androgen at super high concentration can rapidly inhibit 
various cardiac ion currents, including L-type Ca2+ currents (ICa,L), T-type Ca2+ currents 
(ICa,T), slowly- and rapidly-activating delayed rectifier K+ currents (Iks, Ikr), transient outward 
current (Ito), and inwardly rectifying K+ current (see reviewed111). At physiological levels, 
androgen and progesterone can potentiate Iks, and attenuate ICa,L112-113. On the other hand, 
chronic androgen treatment can increase the protein expression level and single-channel 
activity of Ca2+ channel114.  
HERG K+ channel can also be modulated by sex hormones. Estrogen at 30 μmol/L can 
rapidly inhibit Ikr 115. While at the physiological range, both testosterone and progesterone 
has no acute effect on Ikr 112-113. However, chronic treatment with androgen increases cardiac 
Ikr in a rabbit model, which is correlated to the gender difference of QT interval and cardiac 
Ikr density, although the potential molecular mechanisms are unknown116-117. These reports 
indicate that HERG K+ channel may be an important target for sex hormone and the 
modulation would explain the gender and development related arrhythmia. The chronic 
effects of sex hormones on HERG K+ channel are important as the levels of sex hormones 
are relatively stable 118-119. 
1.11 Purpose of this study 
The purpose of this thesis is to systematically investigate the effect of sex hormones on 
HERG K+ channel expression, trafficking and function. Specifically, current study sought to: 
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I. screen sex hormones in a heterologous expression system and find out which 
hormone(s) may affect HERG K+ channel function. Western blotting analysis and patch 
clamp will be used to study HERG channel expression and function. 
II. investigate the effect of sex hormones on biogenesis of HERG K+ channel function. 
RT-PCR, Western blotting, and pharmacological manipulation will be employed to study the 
transcriptional and translational mechanisms for the effect of sex hormones on HERG 
channel expression.  
III. examine the effect of sex hormones on trafficking of HERG K+ channel function. 
Western blotting, confocal microscopy, biological assay and pharmacological manipulation 
will be employed to study HERG trafficking. 
IV. investigate the effect of sex hormones on protein degradation of HERG K+ channels. 
Western blotting, biological assay and pharmacological manipulation will be employed to 
study HERG protein degradation. 
V. study the effect of sex hormones on ERG K+ channel in cardiac tissues.  Rabbit or 
neonatal rat cardiac myocytes will be used to study the effect of sex hormones on the Ikr 
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Proarrhythmic drugs induce torsade de pointes (TdP), a life-threatening arrhythmia, more 
frequently in women than men 120. The slower rates of cardiac repolarization and the longer 
QT intervals in women compared to men are suspected to be responsible for the greater risk 
in women 121-122. Latest clinical and basic studies suggest that androgens may be a key factor 
for the sex difference in heart rate-corrected QT interval (QTc). The QTc intervals were 
shortest in post-pubescent males who have higher androgen concentration, in normal 
populations and in families with inherited long QT syndrome (LQTS)122-123. Cardiac 
repolarization periods in castrated men and normal women who have lower androgen 
concentration were longer than those in normal men and women with virilization who have 
higher androgen concentration124. Moreover, testosterone replacement therapy restored male 
ECG patterns of repolarization in the castrated men124. In animal experiments, androgen 
replacement treatment also restored the prolonged QT intervals in orchiectomized male 
rabbits 116. Taken together, these experiments indicate that androgens may play important 
roles in the gender difference in QTc, which contributes to the higher risk of developing 
drug-induced TdP  in women120. 
HERG K+ channel is one of the ion channels controlling the repolarization of action potential 
in cardiac myocytes125-127. Malfunction of HERG channel caused by mutations or drugs can 
prolong QT intervals and induce TdP arrhythmia125, 128-129. The finding that  IKr current 
densities in male rabbit ventricular myocytes are significantly higher than those in the female 
117 indicates that the modulation of androgen on ERG/IKr may play a role in the sex 
difference of QT intervals. Later, this research group reported that androgen replacement 
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treatment increased IKr currents but had no effect on ERG mRNA levels in gonadectomized 
rabbit hearts, which suggests that androgen modulate IKr in a post-translation mechanism116. 
It is well established that the heart is a target organ of androgens130, but the presence of 
androgen receptor (AR) in the heart is controversial131-134. Recently, Ahrens-Fath and 
colleagues reported that AR transcript levels were very low in human heart compared to 
those in the liver or testis; however, the transcript level of AR45, a naturally occurring 
variant of AR, was very high in human heart tissue 135. This data suggested that in the heart 
AR45 may be the main receptor for androgen. In this study, we investigated the effect of 
androgens on HERG protein expression and function in heterological expression system and 
isolated rabbit cardiac myocytes.  
2.2 Materials and Methods 
2.2.1 Materials 
5β-dihydrotestosterone (5β-DHT) was purchased from Steraloids. R1881 was from NEN. 
PD98059 and U0126 were from Merck. All other reagents were from Sigma. Testosterone, 
5α-dihydrotestosterone (5α-DHT), 5β-DHT, progesterone, estradiol and flutamide were 
dissolved in ethanol as stock solutions.  N-acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN), 
cycloheximide (CHX), MG132, R1881 and bafilomycin A1 were dissolved in DMSO as 
stock solutions. The final ethanol and DMSO concentrations were no more than 0.2%. 
2.2.2 Cell culture and transfection 
Human embryo kidney (HEK293) and Chinese hamster ovary (CHO) cells are androgen 
receptor negative cells 136-137. HERG-HEK293 and CHO cells were cultured in RPMI 1640 
(GIBCO, USA) or F-12 (Sigma, USA) cell culture medium, respectively, supplemented with 
10% fetal bovine serum (FBS, Hyclone, USA) and penicillin-streptomycin (GIBCO, USA) at 
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37°C in a 5% CO2 atmosphere. We established a HEK293 cell line stably expressed HERG 
K+ channels, HERG-HEK293. Briefly, HEK293 cells were transfected with HERG-myc 
plasmid in pCI-Neo vector (Promega, USA). The stable clones were selected by culturing in 
medium containing G418 (800 µg/ml) and confirmed by Western blot analysis and 
electrophysiological study. For biochemical analysis, pSG5-AR45, pSG5-AR or GFP were 
transiently transfected into HERG-HEK293 cells with Lipofectamine2000 (Invitrogen, USA). 
Briefly, HERG-HEK293 cells were cultured in RPMI 1640 medium supplemented with 3% 
FBS for 1 day and then were transfected with AR45, AR or GFP and kept in the above 
culture medium overnight. After serum starving for 16 h in RPMI 1640 medium with 0.5% 
FBS, cells were treated with androgens. For mechanism studies, inhibitors were added to 
culture medium 1 hour before and during androgen treatment. For electrophysiological 
studies, CHO cells were transiently transfected with cDNAs of HERG, AR45 and GFP by 
electroporation as described previously 44-45. Briefly, CHO cells were electroporated (single 
160 V pulse for 15 ms) with 4 μg HERG, 4 μg AR45 and 2 μg GFP cDNAs in a 2-mm gap 
cuvette using a Gene Pulser Xcell (BIO-RAD). After electroporation, the cells were plated 
sparsely and grown on sterile glass coverslips in 60-mm tissue culture dishes. Cells were 
serum starved following the same protocol as mentioned above in the protocol for 
biochemical analysis. Forty eight to 72 hours after transfection, cells were used for 
electrophysiological studies. 
2.2.3 Isolation of rabbit cardiac myocytes 
Myocytes were isolated from rabbit heart via enzymatic digestion as described previously 44-
45. The heart was quickly excised from anesthetized male rabbits (1 month), and perfused 
with calcium free Tyrode’s solution (at 37oC) containing (in mM) 137 NaCl, 5.4 KCl, 1 
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MgCl2, 10 HEPES, and 10 glucose. Then, the perfusion solution was changed to the 
Tyrode’s solution containing 1 mg/ml collagenase (Worthington type II) and 0.28 mg/ml 
protease (type XIV, Sigma) and perfused for 20-25 minutes. The ventricular tissue was then 
cut into small pieces filtered through a 250 μm mesh screen. The cells were washed and the 
calcium concentration of Tyrode’s solution was adjusted to 1.25 mM gradually. Isolated 
myocytes were resuspended in M199 medium and plated into laminin (Sigma)-coated Petri 
dishes. Cells were treated with androgens with the same protocols as described above.  
2.2.4 Western blotting analysis 
Cells were washed with ice-cold PBS and then ice cold lysis buffer (150mM NaCl, 25mM 
Tris-HCl pH 7.5, 5mM EDTA, 1% NP-40, 0.4% deoxycholic acid and EDTA-free protease 
inhibitor cocktail tablets (Roche Pharmaceuticals)) was added. Lysates were rocked for 1 
hour at 4 °C and then centrifuged at 14,000 × g for 10 min at 4 °C. The supernatants were 
assayed for total protein content (Bio-Rad Protein Assay), and equal amounts (50-100 µg) of 
cell lysate protein were subjected to SDS-PAGE analysis. Protein samples were combined 
with 4 × SDS-PAGE sample buffer (4% (w/v) SDS, 40% glycerol, 20% (v/v) β-
mercaptoethanol, 0.004% (w/v) bromphenol blue, 125 mM Tris buffer, pH 6.8) incubated for 
5 min at room temperature, separated on a 8-10% SDS-PAGE, and electrophoretically 
transferred onto 0.2 µM nitrocellulose membrane (Bio-Rad Laboratories). Membranes were 
blocked in 10% non-fat dry milk and 0.1% Tween 20 in TBS for 1 h at room temperature, 
and incubated with appropriate primary antibodies (1:250 to 1:1000 dilutions in 5% bovine 
serum albumin (BSA, Sigma) and 0.1% Tween 20 in TBS overnight at 4 °C. The membranes 
were then washed with 0.1% Tween 20 in TBS and incubated with appropriate horseradish 
peroxidase-conjugated secondary antibodies (1:10,000 to 1:50,000 dilution) for 1 h at room 
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temperature. After 3 washes as above, horseradish peroxidase-bound protein was detected by 
chemiluminescence (Pierce, SuperSignal West Pico Chemiluminescent Substrate). Anti-myc 
mouse monoclonal 9E10 and anti-tubulin rabbit monoclonal antibodies were from Sigma. 
Anti-phosphorylated extracellular signaling-regulated kinase 1/2 (ERK1/2) antibody was 
from Cell Signaling. Anti-Kv11.1 (HERG)-Extracellular antibody was from Alomone Labs. 
Other antibodies were from Santa Cruz Biotechnology, Inc. All gels illustrated in the figures 
are representative examples from 4 to 8 independent experiments. ß-tubulin was applied as 
an internal control to normalize protein loading. The intensity of bands was quantified using 
LabWorksTM Image Analysis software (UVP).  
2.2.5 Cycloheximide-based protein chase experiment 
After posttransfection for 12 h, the medium was replaced with fresh RPMI 1640 plus 0.5% 
FBS with/without 5α-DHT. Eight hours later, cycloheximide (40 μmol/L) was added into 
medium to stop protein synthesis. Cells were then harvested at different time points (0, 6, 12 
and 24 h) after cycloheximide treatment. Total cell lysates were analyzed by Western blotting 
as described above. The amount of HERG remaining at each time point was normalized with 
the original HERG amount at time zero. Protein degradation rate is expressed as half-life 
(t1/2), the time for degradation of 50% of the protein. 
2.2.6 RT-PCR 
Cells were rinsed twice in cold sterile PBS and total RNA was extracted by RNeasy Kits 
(Qiagen) following manufacturer’s instruction. Total RNA was quantified by 
spectrophotometric analysis and checked for purity and quality by running a small aliquot on 
a 1% agarose gel. RT-PCR was carried out using QIAGEN® one-step RT-PCR kit (Qiagen). 
The following primers were used to examine the mRNA expression of HERG: forward: 1999 
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5’-TCCAGCGGCTGTACTCGGGC-3’, reverse: 2573 3’-
GGACCAGAAGTGGTCGGAGAACTC-5’. As a quality control, PCR amplification of the 
messenger relative to the housekeeping gene GAPDH was performed using the following 
primer pair: forward: 1644 5’-TGATGACATCAAGAAGGTGGTGAAG-3’; reverse: 1883 
5’-TCCTTGGAGGCCATGTAGGCCAT-3’. Reverse transcription was performed at 50°C 
for 30 min. PCR protocols consisted of a 15 min initial activation step at 95°C, followed by 
25 cycles of amplification. Each cycle included 1 min at 94°C, 1 min at 55°C and 1 min 
extension at 72°C (30 s each step for GAPDH). The reactions were terminated by an 
elongation step at 72°C for 10 min. PCR products were analyzed with 1% agarose gel 
electrophoresis and imaged by the Multigenius Bioimaging system (Syngene, UK).  
2.2.7 Confocal microscopy 
HERG-HEK293 cells seeded onto glass coverslips were subject to formaldehyde fixation 
before indirect immunofluorescence staining. Primary antibodies were detected with Alexa 
Fluor 568–conjugated anti-goat Ig and Alexa Fluor 488–conjugated anti-rabbit Ig (WGA; 
Invitrogen). After staining, coverslips were mounted with Prolong Gold antifade reagent 
(Invitrogen), and confocal images were acquired using Leica TCS SP5 confocal system. 
Alexa-488 images were acquired with excitation at 488 nm using an argon laser. Alexa-568 
images were acquired with excitation at 543 nm using a helium neon laser. Dual-color 
analysis was done with appropriate single-color controls with individual channels recorded 
sequentially. Instrument settings were adjusted to obtain minimal saturated pixels, and where 
semiquantitative comparisons were done, the settings were kept constant. Negative controls 
include slides probed with either primary antibody or secondary antibody alone. 
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2.2.8 Patch Clamp recording 
Cells on cover slips were taken directly from the cell culture incubator and placed in an 
acrylic/polystyrene perfusion chamber (Warner Instruments) for electrophysiological 
measurements. Patch pipettes were pulled and polished to obtain a tip resistance of 2-3 MΩ 
in the patch clamp solutions. For whole-cell voltage-clamp the pipette solution consisted of 
(in mM) KCl 126, MgSO4 2, CaCl2 0.5, EGTA 5, Mg-ATP 4, and HEPES 25 (pH7.2, 
osmolality: 280±10 mOsm). External bath solution consisted of (in mM) NaCl 150, CaCl2 
1.8, KCl 4, MgCl2 1, glucose 5, and HEPES 10 (pH7.4; osmolality: 320±10 mOsm). All 
experiments were carried out at room temperature (20-22º C). Cells were studied on an 
inverted microscope (Nikon) equipped with electronic patch-pipette micromanipulators 
(Burleigh) and epifluorescence optics for GFP transfected cells.  An Axopatch-200B patch 
clamp amplifier (Axon Instruments) was used for voltage-clamp measurements.  The series 
resistances were about 9 to 10 MΩ. Voltage-clamp protocols were controlled using 
pClamp9.2 acquisition and analysis software. To elicit HERG K+ currents depolarizing 
voltage pulses were applied to various levels from a holding potential of –70 mV for 4 s 
followed by stepwise repolarization to –70 mV to measure outward tail currents. Signals 
were analog-filtered at 2,000 Hz and sampled at 5,000 Hz.  Voltage-dependent activation 
data were fitted to a Boltzmann equation: I = 1/(1+exp[(Vh-V)/k]), where I is the relative tail 
current amplitude, V is the applied membrane voltage, Vh is the voltage at half-maximal 
activation, and k is the slope factor.  
2.2.9 Statistics 
Values presented are means ± SE. ANOVA was employed for statistical analysis of the data 




2.3.1 Androgen up-regulated expression of HERG protein via AR45 
Firstly, we examined the effects of androgen on HERG protein expression in the presence 
and absence of androgen receptors (AR and AR45). 5α-DHT, a potent and non-aromatisable 
androgen, increased both mature (~155 kDa) and immature (~135 kDa) forms of HERG 
protein significantly in HERG-HEK293 cells transfected with AR45, but did not change 
HERG protein expression in HERG-HEK293 cells transfected with AR or GFP plasmids 
(Figure 2-1 A). Similar results were also observed in HEK293 cells that transiently co-
transfected HERG cDNA with AR45, AR or GFP cDNAs (data not shown). These data 
suggest that 5α-DHT may increase HERG protein abundance via stimulating AR45, but not 
AR. Interestingly, AR but not AR45 increased HERG protein level in a hormone-
independent manner. This upregulation may arise from intrinsic hormone-independent 
activity of AR138.  For the following studies, we studied HERG-HEK293 cells transfected 
with AR45 plasmids, unless otherwise stated. 
Then we studied the concentration-dependent effect of androgen on HERG protein. Figure 2-
1 B shows that 5α-DHT increased HERG protein levels in a dose-dependent manner, and the 
concentration of half maximal effect (EC50) is 1.04 ± 0.54 nmol/L. The EC50 of 5α-DHT is 
within the physiological concentration range in men but not women. As it is reported that 
the serum 5α-DHT level is 1.5±0.8 nmol/L in men 119 and around 0.02 nmol/L in 
women139. The maximum effect was observed when using 10 nmol/L of 5α-DHT, and this 
concentration (10 nmol/L) was chosen for the other experiments. 
We also tested other three androgens (testosterone, 5β-DHT, and R1881) and found that all 





Figure 2-1 Effect of androgens on HERG protein in HERG-HEK293 cells transfected with GFP, AR or AR45. 
(A) 5α-DHT treatment (10 nmol/L, 24 h) upregulated HERG protein expression in HERG-HEK293 cells 
transfected with AR45, but not in the cells transfected with GFP or AR plasmids. (n = 6 to 8 per group). (B) 
Concentration-dependent effect of 5α-DHT in HERG-HEK293 cells transfected with AR45. Western blot 
analysis indicated that treatment with 5α-DHT (10-10-10-6 M) for 24 h increased HERG protein level in a 
concentration-dependent manner. (n = 6 to 7 per group). (C) Treatment with 5α-DHT (10 nmol/L), 5β-DHT (10 
nmol/L), testosterone (100 nmol/L) or R1881 (10 nmol/L) for 24 h significantly increased HERG protein 
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abundance. (n = 4 to 8 per group). (D) Treatment with progesterone (P4, 30 and 300 nmol/L) or estradiol (E2, 
10 and 100 nmol/L) for 24 h failed to affect HERG protein abundance. (n = 6 per group). (E) The effect of 
androgen (10 nmol/L 5α-DHT) and antiandrogen (10 μmol/L flutamide) on HERG protein levels (n = 8 per 
group). Representative Western blots are shown in the left panels. The percentage increment in protein density 
on treatment with 5α-DHT is shown in the right panels. HERG protein abundance was normalized to β-tubulin. 
Data are means ± S.E. *, p<0.05. Copyright 2008, The Endocrine Society. 
On the other hand, other sex hormones as progesterone (30 and 300 nmol/L) and 17-β 
estradiol (10 and 100 nmol/L) did not change HERG protein level (Figure 2-1 D). These data 
suggest that androgens stimulate AR45 and up-regulate HERG protein expression 
specifically.  
To further confirm the involvement of androgen receptor, flutamide, an antiandrogen, was 
used. It was found that flutamide (10 μmol/L) attenuated the effect of 5α-DHT (Figure 2-1 E). 
Interestingly, flutamide itself also increased HERG protein level and this may from the non-
genomic androgen-like effects of the drug 140-141.  
2.3.2 The effect of 5α-DHT on HERG protein level was mediated via a post-
translational mechanism 
The increase of HERG channel protein level may be resulted from enhanced protein 
synthesis or decreased protein degradation. Firstly, we tested whether androgen increased 
HERG protein level via a genomic effect. The mRNA level of HERG was examined by RT-
PCR, and it was found that androgen treatment did not change HERG mRNA level (Figure 2-
2 A). We also tested a plasmid with same vector but inserted with kir2.1 gene. However, the 
stimulation of AR45 by 5α-DHT failed to change kir2.1 protein level (Figure 2-2 B). To test 
whether augmentation of HERG protein level was due to the change of protein synthesis, 
cycloheximide, a protein translation inhibitor, was employed. It was found that 
cycloheximide alone decreased HERG protein levels, and it did not prevent the stimulatory 
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effect of androgen (Figure 2-2 C). Taken together, these data indicate that a post-translational 
mechanism is underlying the effect of 5α-DHT.  
 
Figure 2-2 Post-translational effect of 5α-DHT on HERG protein levels.  (A) RT-PCR for the measurement of 
HERG mRNA levels with 5α-DHT treatment, the HERG mRNA levels were normalized with GAPDH (n=4). 
(B) Immunoblot analysis showed that 5α-DHT (10 nmol/L) had no effect on Kir2.1 protein level (n=4). (C) 
Immunoblot analysis showed that 5α-DHT (10 nmol/L) increased HERG protein levels in the presence or 
absence of cycloheximide (40 µM). Cycloheximide was applied 1 h prior to administration of 5α-DHT (n = 5 
per group). Data are means ± S.E. *, p<0.05. Copyright 2008, The Endocrine Society. 
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2.3.3 5α-DHT increased HERG protein abundance at the cell surface and in 
the intracellular compartments 
To examine the effect of androgen on HERG protein trafficking, we performed double 
immunofluorescence staining. GM130 was chosen as a marker of the Golgi complex and 
calnexin as a marker of the endoplasmic reticulum (ER). Chronic androgen treatment 
increased HERG signals in the plasma membrane, the ER and the Golgi complex, but 
without clear preferential colocalization with GM130 or calnexin (Figure 2-3). This result 












Figure 2-3 Effect of 5α-DHT on subcellular localization of HERG.  Immunofluorescence assays with double 
staining for HERG-myc (red channel) and either the Golgi marker GM130 (A) or the ER marker calnexin 
(B)(green channel).  5α-DHT treatment (10 nmol/L for 24hrs) resulted in globally increased HERG signal in 
both compartments as well as on the surface. Copyright 2008, The Endocrine Society. 
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2.3.4 The effect of 5α-DHT on HERG protein in the presence of protein 
degradation inhibitors 
Then we tested the involvement of protein degradation for the effect of 5α-DHT. HERG can 
be degraded by either lysosomal or proteasomal degradation pathways106, 108. In this study, 
we employed a lysosomal protease inhibitor, bafilomycin A1, and two proteasome inhibitors, 
MG132 and ALLN. Bafilomycin A1, MG132 and ALLN alone significantly increased 
HERG protein level, which is in agreement with previous studies that HERG proteins can be 
degraded by lysosome or proteasome (Figure 2-4). Moreover, these inhibitors significantly 
abolished the effect of 5α-DHT (Figure 2-4). These data suggest that androgen may inhibit 
protein degradation. 
 
Figure 2-4 Effect of 5α-DHT on HERG protein levels in the presence and absence of proteasome and 
lysosomal protease inhibitors. Immunoblot analysis shows that the upregulation of HERG protein abundance 
was abolished by two proteasome inhibitors ALLN (50 μM) and MG132 (50 μM), and a lysosome inhibitor, 
bafilomycin A1 (100 nmol/L). Inhibitors were applied 1 h prior to administration of 5α-DHT. Data are means ± 





2.3.5 5α-DHT prolonged the half-life of HERG protein 
To confirm the above findings, we employed the cycloheximide chase assay to study the 
turnover rates of HERG protein. It was found that 5α-DHT treatment delayed HERG protein 
degradation significantly at different time points. The half-life time (t1/2) of HERG was 
prolonged from 12.4 ± 1.5 h (control) to 16.3 ± 1.2 h (5α-DHT treatment). This result 
suggests that androgen can enhance HERG protein stability.  
 
Figure 2-5 Effect of 5α-DHT on HERG protein stability. HERG protein stability was examined with 
cycloheximide-based chase assay. Immunoblot analysis shows that treatment with 5α-DHT (10 nmol/L) 
prolonged HERG protein half-life. Data are means ± S.E. n = 5 per group, *, p<0.05. Copyright 2008, The 
Endocrine Society. 
2.3.6 The effect of 5α-DHT on HERG protein level in the presence of ERK1/2 
inhibitors 
Several studies demonstrated that androgens can exert non-genomic effects via ERK1/2 
MAPK signaling pathway 142-146. To examine the involvement of ERK1/2 in the effect of 5α-
DHT on HERG protein, we first tested whether 5α-DHT treatment can induce the 
phosphorylation of ERK1/2.  It was found that 5α-DHT induced phosphorylation of ERK1/2 
(a marker for ERK 1/2 activation) in a dose-dependent manner, in the HERG-HEK293 cells 
transfected with AR45 but not in the cells transfected with GFP (Figure 2-6 A). This result 
indicates that androgen can activate ERK1/2 via AR45. Then we tested whether ERK1/2 
inhibitors (PD98059 and U0126) can abolish the effect of androgen on HERG channel. It 
was found that PD98059 and U0126 did not change HERG protein level, while the two 
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inhibitors countered the effect of 5α-DHT on HERG protein abundance (Figure 2-6 B). 
Taken together, these data suggest that the activation of ERK1/2 mediates the increase of 
HERG channel protein level via activating AR45by androgen. 
 
Figure 2-6 Effect of 5α-DHT on HERG protein levels was via activation of ERK1/2. (A) Immunoblot analysis 
showing that treatment with 5α-DHT (10-10-10-7 M) for 30 min concentration-dependently induced 
phosphorylation of ERK1/2 in cells transfected with AR45 (n = 4), but not in cells transfected with GFP (n=6); 
(B). Immunoblot analysis showing that two ERK1/2 inhibitors, PD98059 (20 µM) and U0126 (20 μmol/L), 
abolished the effect of 5α-DHT on HERG protein levels (n = 4 to 7 per group). Inhibitors were applied 1 h prior 
to administration of 5α-DHT. Data are means ± S.E. *, p<0.05. Copyright 2008, The Endocrine Society. 
2.3.7 5α-DHT increased HERG currents in CHO cells co-expressing HERG K+ 
channel and AR45 
The data described above indicate that chronic 5α-DHT treatment can increase HERG 
protein level. Here we employed patch clamp recording to investigate whether androgen 
treatment also increased HERG K+ channel function. CHO cells bearing little endogenous 
potassium currents were chosen for the electrophysiological study. Chronic 5α-DHT 
treatment increased HERG K+ current densities (Figure 2-7 A-B), but did not change 
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current kinetics (insets of Figure 2-7 B). When fitting the activation curves derived from 
tail current, it was found that chronic androgen treatment did not change voltage 
dependency of  activation (V1/2 : Con: -20.4±3.4 mV; 5α-DHT: -21.3±2.2 mV, n=8, 
p>0.05). These data suggest that 5α-DHT increased HERG K+ current density mainly 
through the elevated HERG protein levels.  
 
Figure 2-7 Effect of 5α-DHT on HERG K+ channel activity in CHO cells transfected with HERG K+ channels 
and AR45. (A) Representative current tracings showing the effect of 5α-DHT (10 nmol/L, 24 h). Currents were 
elicited by 4.5 s depolarizing steps to various levels (between 40 and –80mV) followed by repolarizing steps to 
–70 mV. Scale bars, 20 pA/pF and 1 s. (B). Current-voltage (I-V) relation curve plotted from current measured 
at the end of the depolarizing test pulses. Inset, data were normalized to unity with and without 5α-DHT. (B) 
Voltage-dependent activation curves plotted from peak tail currents during a repolarizing step to –70 mV after 
depolarizing to various voltages. Inset, the same data normalized to the maximum current in the same curve. 
Square: without 5α-DHT; Triangle: with 5α-DHT treatment. Data are means ± S.E. n = 8 per group. *, p<0.05.  
Copyright 2008, The Endocrine Society. 
2.3.8 5α-DHT increased ERG protein level in isolated rabbit cardiac 
myocytes 
To determine whether chronic androgen treatment could also increase native ERG protein 
level, isolated rabbit cardiac myocytes were cultured in M199 medium in the presence or 
absence of 5α-DHT for 24 h. It was found that 5α-DHT also significantly increased ERG 
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protein level (Figure 2-8), which is in agreement with the previous study that in vivo 5α-
DHT replacement increased cardiac mycocyte Ikr density in orchiectomized male rabbits116. 
 
Figure 2-8 Effect of 5α-DHT on ERG protein levels in isolated rabbit cardiac myocytes. Immunoblot analysis 
shows that treatment with 5α-DHT (10 nM) for 24 h upregulated ERG protein expression in rabbit cardiac 
myocytes. Data are means ± S.E. n = 4 per group, *, p<0.05. Copyright 2008, The Endocrine Society. 
2.4 Discussion 
AR45 is a naturally occurring splice variant of human androgen receptor 135. It has a different 
transcription start point and a novel seven amino-acid long N-terminal extension replaced the 
region encoded by exon 1 of the AR gene. AR45 shares the same sequence with AR which 
includes DNA-binding domain, hinge region and ligand-binding domain. The survey on 
human tissues indicated that AR45 transcript is very high in the heart135. In this study, we 
found that the stimulation of AR45, but not AR, increased HERG protein level. We therefore 
further examined the underlying mechanisms for the effect of AR45. 
The present study demonstrated for the first time that AR45 stimulation increased HERG 
protein level via a non-genomic effect. We investigated the effect of 5α-DHT on HERG 
protein level in the presence of cycloheximide, which decreased HERG protein abundance. 
However, cycloheximide failed to prevent the effect of 5α-DHT.  We also noticed that 5α-
DHT failed to change the mRNA level of HERG by using RT-PCR analysis. Furthermore, 
flutamide, a pure antiandrogen which binds to androgen receptor and produces non-genomic 
effects141, also increased HERG protein level. Taken together, these data strongly suggest 
that the augmentation of HERG protein abundance is not via increase of de novo protein 
54 
 
synthesis. This is in agreement with the previous finding that AR45 had very weak or no 
transactivation efficiency135. 
Gong and colleagues demonstrated that HERG proteins, especially the core-glycosylated 
form of HERG protein, can be degraded in the proteasome108, while Chapman and colleagues 
reported that HERG proteins can be degraded in the lysosome106. In this study, inhibition of 
either degradation pathway significantly increased HERG protein levels and attenuated 
the effect of 5α-DHT. These data indicate that both proteasomal and lysosomal degradation 
pathways are involved in the stimulatory effect of androgen on HERG abundance. To 
confirm this finding, we measured HERG protein stability with cycloheximide chase assay 
and found that 5α-DHT significantly prolonged HERG half-life. 
Recent studies demonstrated that ERK1/2 activation regulated protein stability via 
modulating protein degradation directly or indirectly147-149. It was reported that ERK1/2 
may phosphorylate MAP Kinase Phosphatase-1 directly and therefore inhibit the 
degradation of this protein147. ERK1/2 can also regulate protein degradation indirectly. 
For example, activation of ERK1/2 reduced GATA3 degradation by stimulating E3 ligase 
Mdm2 149 and promoted p21 protein by enhancing cyclin D1-imposed block148. We 
therefore investigated the involvement of ERK1/2 in the inhibitory effect of androgens on 
HERG protein degradation. It was found that androgen induced ERK1/2 phosphorylation 
via AR45 in the same concentration range needed for the effect on HERG protein level.  
Blockade of ERK1/2 with two specific inhibitors PD98059 and U0126 abolished the 
augmentation of 5α-DHT on HERG protein level. These data clearly suggest that activation 
of AR45 in the heart may enhance HERG protein stability via ERK1/2 pathway.  
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The N-terminal region of AR not only determines the ability of regulating gene 
transcription but also affects the binding affinity of signaling molecules (i.e. p85α of 
PI3K) to the receptor135, 150. Interestingly, a similar isoform of estrogen receptor α (ERα), 
ERα46, which lacks AF-1 as AR45, modulates membrane initiated estrogen actions more 
efficiently than ERα151, and regulates transcriptional activation less efficiently152. These 
findings and the data from our study suggest that AF-1 in the N-terminal region of sex 
hormone receptors is critical for the genomic effects of sex hormones. AR and ERα, both 
of which have AF-1, may contribute more to the genomic effects, whereas AR45 and 
ERα46 may play a more important role in non-genomic functions within a restricted 
subset of tissues. The ratios of ERα46/ERα153-154 and AR45/AR135 vary in different types 
of cells and at various developmental stages, which suggests that differential expression 
of alternatively spliced ER or AR variants may contribute to tissue-specific actions of sex 
hormones.  
Our results also show that long-term 5α-DHT treatment only increased HERG current 
density but failed to alter HERG current kinetics or voltage-dependence. However, Liu 
and colleagues found that in vivo 5α-DHT replacement on orchiectomized male rabbits 
shifted the V1/2 of the Ikr current to a more negative membrane potential 116. The discrepancy 
between our and Liu’s data could arise from the effect of 5α-DHT on other isoforms of 
ERG, β subunits or other impinging signaling pathways not present in our heterologous 
system. The channel contribution to the cardiac Ikr is comprised not only of ERG, but also 
of ERG1b (N-terminal truncated transcriptional variant of ERG) and β subunits such as 
MiRP151, 80, 155. To better understand the modulation of androgens on Ikr, further studies 
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are warranted to investigate the effect of androgen on ERG1b and β subunit expression 
and function.   
In this study, we also examined the effect of other sex hormones on HERG protein 
expression. We found progesterone (30 and 300 nmol/L) and 17-β estradiol (10 and 100 
nmol/L) failed to alter HERG protein level. These data suggest that androgens may up-
regulate HERG channel protein via stimulation of AR45 specifically.  
We also examined the effect of androgens and antiandrogen on HERG protein level. Among 
them, testosterone is the predominant androgen and can be converted to 5α-DHT and 5β-
DHT, and even estrogens. The serum concentration of testosterone is about 10 fold greater 
than that of 5α-DHT. R1881 is a synthetic androgen with high affinity for the androgen 
receptor141. All of these androgens up-regulated HERG protein abundance in the present 
study. 5α-DHT was chosen for the rest of the study, because it is a natural, non-aromatisable 
androgen with high binding affinity and specificity for the androgen receptor. Flutamide has 
relatively low binding affinity for androgen receptor, and does not possesses any androgenic 
genomic activity 141, 156. It has been widely accepted that antiandrogens can antagonize 
genomic effect of androgens. In the present study, we found that flutamide mimic the effect 
of 5α-DHT, implying that the effect of androgen on HERG abundance was not a genomic 
effect. Recent studies showed that similar to androgen, antiandrogen can also activate 
ERK1/2 142, 157. This may explain why flutamide, as an antiandrogen, also upregulated HERG 
protein expression.  The general cardiovascular safety of clinical uses of flutamide may be 
due, in part, to its lack of inhibition of the non-genomic functions of AR45.  
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We investigated the molecular mechanism with the heterological expression system and then 
we also examined the physiological significance in the native tissue. In this study, we found 
that chronic 5α-DHT treatment significantly increased ERG protein level in rabbit cardiac 
myocytes, which further confirms the existence of such regulation in cardiac tissue. 
In conclusion, our study demonstrates that chronic stimulation of cardiac isoform AR45, but 
not AR, increased HERG K+ protein level mainly through stabilizing HERG protein via 
stimulation of ERK1/2. This finding may provide a molecular mechanism for the gender 













Chapter 3 Progesterone impairs HERG trafficking by disruption 










Progesterone (P4) is an important steroid hormone involved in the female menstrual cycle, 
pregnancy and embryogenesis. Progesterone can enter the cells and activate the progesterone 
receptor, which in turn modulates the transcription of progesterone response genes. 
Alternatively, it may stimulate various protein kinases directly or indirectly via plasma 
membrane receptors.  It may activate MAPK to regulate the expression and function of 
sodium channels 158 and PI3K/Akt pathway to regulate the function of the slow component of 
the delayed rectifier K+ current (IKs) and L-type calcium channels 113. Progesterone may also 
induce ion channel internalization in oocytes by decreasing the intracellular cAMP level 159.  
Moreover, progesterone can also modulate cellular cholesterol homeostasis by affecting 
cholesterol trafficking, esterification and biosynthesis 160-162. 
During the normal menstrual cycle, progesterone levels increase from 0.6-4.5 nmol/L (the 
preovulatory phase) to 10.5-80 nmol/L (the luteal phase) 163. It was reported that 
progesterone at relatively high levels (<100 nmol/L, comparable to that occurring during the 
luteal phase) had no significant effect on QT interval 164-166. However, recent studies show 
that progesterone may shorten the action potential duration or QT interval 167. This is 
probably because progesterone at this level (such as during the luteal phase) enhances IKs 
and inhibits L-type Ca2+ currents 113.  
If pregnancy occurs, progesterone levels are initially maintained at the luteal level, but may 
increase to 1 µmol/L at term  168. Elevated levels of progesterone are important for the 
implantation of the embryo and the maintenance of a conducive environment for the embryo. 
At such a high level, the corrected QT (QTc) interval is significantly prolonged 169-170. This 
explains why pregnant women are more susceptible to ventricular arrhythmias during 
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pregnancy, labor and delivery 171-174. However, it is interesting to note that in the patients 
with inherited Long QT syndrome (LQTS) the risk for cardiac events is not higher during 
pregnancy than during other periods in life, whereas the risk markedly increases during the 
postpartum period 171, 175. These findings suggest that the mechanisms for pregnancy-induced 
cardiac events in normal healthy women are different from those in the patients with 
inherited LQTS.  
In the fetus, the progesterone level was reported to be very high (~4.5 µmol/L) in umbilical 
cord vein during late stages of pregnancy 168. At this stage, longer QT and QTc intervals were 
reported in fetal magnetocardiography and non-invasive fetal electrocardiography 176-177. 
More importantly, the rate of sudden death is higher in the uterus than at most other times in 
the human life cycle. Although the major reasons remain unknown, several studies of 
newborns suggest that QT prolongation and the increased risk of ventricular arrhythmias may 
account for the significant mortality 178-180. This may be the same for stillbirth as several case 
reports indicate that LQTS is one cause for otherwise unexplained fetal demise 181.  
The human ether-a-go-go-related gene (HERG) K+ channel, which encodes the α-subunit of 
the rapid component of the delayed rectifier K+ current (IKr), is largely responsible for the 
repolarization of action potentials in cardiac myocytes. Inherited mutations or drug-induced 
blockade of the HERG channel prolongs QT intervals and increases the risk of lethal 
arrhythmia. Trafficking to the plasma membrane is very important for HERG channel and 
defects in trafficking, caused either by mutation of HERG gene or by drugs, can affect 
HERG function significantly.  
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The function of the HERG channel is important for embryo development as impaired HERG 
channel function not only induces LQTS in embryo, but also affects the structure of the heart 
73, 182 and even causes embryonic lethality 182. However, the effect of progesterone on HERG 
K+ channel function remains unclear. Since the progesterone level during late pregnancy is 
very high, we hypothesized that progesterone may contribute to prolonged QT intervals and 
the sudden cardiac death in fetus and perhaps in the pregnant women as well. This study was 
therefore designed to examine the effect of progesterone on protein expression, trafficking 
and function of HERG K+ channels in heterologous expression systems and rat neonatal 
cardiac myocytes.  
3.2 Materials and Methods 
3.2.1 Materials 
PD98059 and LY294002 were from Merck. Simvastatin was from Eurodrug Laboratories 
(Belgium). All other reagents were from Sigma. Progesterone, cholesterol, and RU486 were 
dissolved in ethanol as stock solutions. Cycloheximide, PD98059 and LY294002 were 
dissolved in DMSO as stock solutions. The final ethanol and DMSO concentrations were less 
than 0.2%. The GFP-Rab9 plasmid was a gift from Dr Suzanne Pfeffer, Stanford University. 
3.2.2 Cell culture and transfection 
We used HEK293 cells to generate a HERG-HEK293 cell line that stably expresses HERG 
K+ channels with a myc tag 183. HERG-HEK293 cells and CHO cells were cultured in RPMI 
1640 (GIBCO, USA) and F-12 (Sigma-Aldrich, USA) cell culture medium respectively, 
supplemented with 10% fetal bovine serum (FBS, Hyclone) and penicillin-streptomycin 
(GIBCO, USA) at 37°C in a 5% CO2 atmosphere. For mechanism studies, inhibitors were 
added to culture medium 1 hour (unless otherwise stated) before and during progesterone 
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treatment. For electrophysiological studies, CHO cells were transiently transfected with 
cDNAs of HERG and GFP by electroporation as described previously 183. To study the L-
type Ca2+ current, HEK 293 cells were transiently transfected with human Cav1.2 cardiac 
splicing form Cav1.2CM (1a-8a-32-33) constructs (1.25 µg), together with β2a (1.25 µg) and 
α2δ (1.25 µg) using the calcium phosphate transfection method 184. Lipofectamine 2000 
(Invitrogen, USA) was used for the transfection of Myc-Kv1.5, GFP and GFP-Rab9 plasmids. 
3.2.3 Isolation of rat neonatal cardiac myocytes 
Rat neonatal cardiac myocytes were isolated from 1-2 day Sprague Dawley rats via serial 
pancreatin (Sigma)/collagenase II (Worthington Biochemical) digestion.  Cells were cultured 
in DMEM medium supplemented with 10% fetal bovine serum, 5% horse serum, and 
penicillin-streptomycin. To prevent the proliferation of other type of cells, 100 μmol/L BrdU 
was added in the first 24 hours. 
3.2.4 Western blot analysis 
Western blot analysis was performed using whole cell lysates as previously described 183. 
Anti-myc mouse monoclonal 9E10 and anti-tubulin rabbit monoclonal antibodies were from 
Sigma. Other antibodies were from Santa Cruz Biotechnology, Inc. All blots illustrated in the 
figures are representative examples from 4 to 8 independent experiments. ß-Tubulin and 
HPRT were applied as internal controls to normalize protein loading. The intensity of bands 
was quantified using LabWorksTM Image Analysis software (UVP). 
 3.2.5 Confocal microscopy 
HERG-HEK293 cells grown on glass coverslips were subject to formaldehyde fixation 
before indirect immunofluorescent staining. To study the plasma membrane HERG K+ 
channel distribution, cells were incubated with anti-Kv11.1 (HERG extracellular epitope, 
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residues 430-445, between S1-S2 loop) antibody (Alomone Labs) without permeablization, 
and the primary antibody was detected with Alexa Fluor 488-conjugated anti-rabbit Ig (WGA; 
Invitrogen). To study the intracellular HERG K+ channel and ER and Golgi complex 
localization, cells were permeabilized with Triton X-100 or saponin. Then cells were 
incubated with anti-c-myc antibody (Sigma) and anti-GM130 (Golgi complex marker) or 
anti-calnexin antibody (ER marker) (Sigma). Primary antibodies were detected with Alexa 
Fluor 488-conjugated anti-rabbit Ig and Alexa Fluor 568-conjugated anti-mouse Ig (WGA; 
Invitrogen).  After staining, coverslips were mounted with Prolong Gold antifade reagent 
(Invitrogen), and confocal images were acquired using Leica TCS SP5 confocal system 
(Centre for Life Sciences) and Nikon A1R Confocal system (SBIC-Nikon Imaging Centre). 
Image acquisition and analysis procedures were as previously described 183. 
 3.2.6 Filipin Staining 
HERG-HEK293 cells were fixed with formaldehyde and glycine was used to quench extra 
formaldehyde. Cells were then stained with filipin (Sigma-Aldrich) and viewed by 
fluorescence microscopy at magnificent of x20 or x40 times using a UV filter set. 
3.2.7 Cellular cholesterol measurement 
Amplex®Red Cholesterol Assay kit (Molecular Probes) was used to measure cellular 
cholesterol level. HERG-HEK293 cells were lysed with reaction buffer containing 0.1 M 
potassium phosphate, pH7.4, 0.05 M NaCl, 5 mM Cholic acid, 0.1% Triton X-100. Total 
cellular cholesterol was measured in the presence of cholesterol esterase, which hydrolyzed 
cholesteryl esters into cholesterol. Free cellular cholesterol was measured in the absence of 
cholesterol esterase. Bradford assay was used to determine protein concentrations (Bio-Rad).  
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3.2.8 Patch Clamp recording 
Cells grown on cover slips were placed in an acrylic/polystyrene perfusion chamber (Warner 
Instruments) for electrophysiological measurements. Patch pipettes were pulled and polished 
to obtain a tip resistance of 2-3 MΩ in the patch clamp solutions. For K+ channel current 
recording, the pipette solution consisted of (in mmol/L) KCl 126, MgSO4 2, CaCl2 0.5, 
EGTA 5, Mg-ATP 4, and HEPES 25 (pH7.2, osmolality: 280±10 mOsm), whereas external 
bath solution consisted of (in mmol/L) NaCl 150, CaCl2 1.8, KCl 4, MgCl2 1, glucose 5, and 
HEPES 10 (pH7.4; osmolality: 320±10 mOsm). For L-type Ca2+ current recording, the 
internal solution (pipette solution) contained (in mM) 138 Cs-MeSO3, 5 CsCl, 0.5 EGTA, 10 
HEPES, 1 MgCl2, 2 mg/ml Mg-ATP, pH 7.3 (adjusted with CsOH), whereas the external 
solution contained (in mM) 10 HEPES, 140 tetraethylammonium methanesulfonate, 5 BaCl2 
(pH was adjusted to 7.4 with CsOH and osmolarity to 290-310 with glucose). All 
experiments were carried out at room temperature (20-22º C). Cells were studied on an 
inverted microscope (Nikon) equipped with electronic patch-pipette micromanipulators 
(Burleigh) and epifluorescence optics for GFP transfected cells. The Axopatch-200B patch 
clamp amplifier and Axopatch 700B amplifier (Axon Instruments) were used for voltage-
clamp measurements.  The series resistances were about 9 to 10 MΩ. Voltage-clamp 
protocols were controlled using pClamp9.2 software. To elicit HERG K+ currents 
depolarizing voltage pulses were applied to various levels from a holding potential of –70 
mV for 4 s followed by stepwise repolarization to –50 mV to measure outward tail currents. 
Signals were analog-filtered at 2,000 Hz and sampled at 5,000 Hz. Voltage-dependent 
activation data were fitted to a Boltzmann equation: I = 1/(1+exp[(Vh-V)/k]), where I is the 
relative tail current amplitude, V is the applied membrane voltage, Vh is the voltage at half-
maximal activation, and k is the slope factor. The steady state activation of HERG currents 
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was studied based on the tail currents. The peak currents were determined by fitting the tail 
currents with 2-exponential equation and extrapolated back to the moment of repolarization. 
The values of peak currents were normalized with the maximum current value and fitted with 
Boltzmann equation to get the steady state activation curve. To study channel deactivation, 
we activated channels by a voltage pulse to 40 mV, followed by the testing potentials that 
increased in 10 mV increments from -70 to -40 mV. The deactivation constants (fast and 
slow time constants) were derived by fitting the currents with a double exponential function. 
3.2.9 Statistics 
Values presented are as means ± SEM. ANOVA and Tukey’s post-hoc tests were employed 
to assess statistical significance and P-values of < 0.05 were considered to be significant. 
3.3 Results 
3.3.1 Progesterone impairs the maturation of HERG K+ channels  
The concentration-dependent effect of progesterone on HERG K+ channel protein expression 
was first examined. As shown in Figure 3-1 A, there are two forms of the HERG protein in 
HERG-HEK293 cells. The 135 kD form represents the core-glycosylated protein located 
mainly in the ER, and the 155 kD form represents the fully-glycosylated protein located 
mainly in the Golgi complex and plasma membrane. Progesterone at 0.5 µmol/L or higher 
concentration significantly decreased the amount of the mature (fully glycosylated) form, but 
had no significant effect on the immature (core-glycosylated) form of the HERG K+ channel.  
In a subsequent time-course study, the significant inhibitory effect on channel maturation 
was observed after treatment with progesterone for 8 h (Figure 3-1 B). The effect of 
progesterone was reversible as removal of progesterone for 6 h successfully rescued the 
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mature form of HERG (Figure 3-1 C).  The above data suggest that the effect of progesterone 
on HERG maturation is both concentration- and time-dependent. 
 
Figure 3-1. Effect of progesterone on HERG protein expression and maturation in HERG-HEK293 cells. (A) 
Dose-dependent response. Cells were treated with progesterone (0.1-10 µmol/L) for 24 h. n=6. (B) Time-course 
for the effect of progesterone. HERG-HEK293 cells were incubated with progesterone (5 µmol/L) for different 
periods. (C) Time-course for the recovery of progesterone effect after washout. n=4. Mean±SEM, * p<0.05, ** 
p<0.001 vs P4=0 or Time=0.  
3.3.2 Progesterone significantly decreases HERG current density 
The effect of progesterone on HERG current was investigated in cell lines stably expressing 
HERG gene with a whole-cell patch clamp technique. The voltage step protocols are shown 
in figure 3-2 and described in the figure legend. As shown in Figure 3-2 A-B, treatment with 
progesterone (0.5-5 µmol/L, 24 h) concentration-dependently decreased current density at the 
peak of tail current in HERG-HEK293 cells. Acute progesterone treatment (0.05-5 µmol/L) 
for 15 min failed to affect HERG K+ current density (data not shown), which is in agreement 
with the previous study on Ikr 113. These data suggest that the long-term effect of progesterone 
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was not secondary to its direct interaction with HERG channels. We further confirmed the 
effect of progesterone on HERG channel current kinetics in CHO cells, 

































































































































































Figure 3-2.  Effect of progesterone on HERG K+ channel function. (A-B): HERG currents measured in HERG-
HEK293 cells. (A) Representative recordings showing that the currents were suppressed by progesterone (5 
µmol/L, 24 h).  (B) Concentration-dependent effect of progesterone (0.05-5 µmol/L, 24 h) on the peak tail 
currents during a repolarizing step to -70 mV  after depolarization to various voltages. (C-H): HERG currents 
measured in CHO cells. (C) Representative current recordings with or without progesterone treatment. (D) 
Current-voltage (I-V) relation curve plotted from current measured at the end of depolarizing test pulses. Inset: 
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Data were normalized to unity with and without progesterone treatment. (E) Voltage-dependent activation 
curves plotted from the peak tail currents. Inset: Same data normalized to the maximum current within the same 
curve. (F) Steady state activation curves with or without progesterone treatment. Inset showing measurements 
of steady-state activation by fitting and extrapolating back to the moment of repolarization (Red line). Currents 
in (A-F) were elicited by 4 s depolarizing steps to various levels (between -50 and 50 mV) followed by 
repolarizing steps to -50 mV then to -120 mV.   (G-H) Representative recordings and group data showing that 
treatment with progesterone (5 µmol/L, 24 h) did not affect the deactivation kinetics of HERG channels. 
Currents were elicited by depolarization of +40 mV followed by repolarization to -70, -60, -50 and -40 mV. 
Mean±SEM. n=8 cells for each group. * p<0.05 vs the corresponding values in the control group (without 
progesterone treatment). 
which express less endogenous potassium current. As shown in Figure 3-2 C-E, progesterone 
significantly suppressed HERG current density in both current-voltage (I-V) relation curve 
(Figure 3-2 D) and voltage-dependent activation curve (Figure 3-2 E). When the peak 
amplitudes of the tail current were normalized, a marginal shift in voltage-dependent 
activation was observed (Con: 3.8± 0.7 mV; P4: 0.1± 0.8 mV, p>0.05, n=8-10, inset of figure 
2E). There was no significant change in the slope factors (Con: 10.6± 0.6 mV; P4: 11.5± 0.7 
mV). Similar results were observed in the steady state activation curve (Figure 3-2 F). 
Progesterone treatment had no significant effect on the deactivation of HERG currents 
(Figure 3-2 G-H). Overall, prolonged progesterone treatment reduced functional HERG K+ 
channel density on plasma membrane without affecting HERG K+ current kinetics.  
3.3.3 Progesterone preferentially decreases HERG channel protein in the 
plasma membrane 
Since the fully glycosylated form mainly represents the mature channels expressed in the 
plasma membrane, we further investigated the effect of progesterone on HERG K+ channel 
subcellular compartmentalization by performing immunofluorescence labeling. To detect the 
surface expression, cells were incubated with anti-Kv11.1 raised against the extracellular 
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Figure 3-3. Immunofluorescence and Western blotting analysis showing HERG K+ channel cellular distribution 
and ER stress caused by progesterone (5 µmol/L, 24h). (A) Plasma membrane HERG K+ channel proteins 
determined with an antibody against HERG extracellular domain. Cells were not permeabilized. Right panel 
shows the fluorescent signal  intensities of HERG protein collected from the lines across the cells as indicated in 
the brightfield pictures. Values were the averages from ten cells in each group. Red: HERG signals in Control; 
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Blue: HERG signals in progesterone treated cells. (B) Double staining for HERG (red color) with anti-myc 
antibody and ER marker calnexin (green color). Cells were permeabilized with Triton X-100 before incubation 
with antibodies. Progesterone treatment caused accumulation of HERG K+ channel in the dilated ER. Insets, 
enlarged pictures of the indicated boxes to show the co-localization of HERG and ER. (C) Double staining for 
HERG (red color) with anti-myc antibody and Golgi complex marker GM130 (green color).  All these data are 
representatives of three to four independent experiments.  White scale represents 20 μm length. (D) Both 
progesterone (5 µmol/L) and thapsigargin (200 nmol/L) increased CHOP expression in a time-dependent 
manner. Mean±SEM. n=4. * p<0.05 vs the corresponding value at time 0.    
HERG signals at the cell surface (Figure 3-3 A). The signals were quantified with the 
software ImageJ as shown in the right panel. It was found that progesterone significantly 
reduced HERG expression on the plasma membrane (Con: 50.5±7.7 vs P4: 10.4±5.0, p<0.05). 
To further confirm the preferential effect of progesterone, cells were permeabilized and 
double-stained with anti-myc and anti-calnexin (ER marker) or anti-GM130 (Golgi complex 
marker) antibodies. Progesterone caused ER dilation (dotted green signal, anti-calnexin), and 
HERG K+ channels (red signal) accumulated in the dilated ER (Figure 3-3 B). In contrast, 
there is no co-localization between the accumulated HERG K+ channels (red signal) and the 
Golgi complex (green signal, anti-GM130) (Figure 3-3 C). This result indicates that 
progesterone treatment may cause ER stress and affect HERG K+ channel folding and 
trafficking.  
To study progesterone-induced ER stress, we further examined the protein expression of 
CHOP, a hallmark of ER stress. We found that progesterone increased CHOP protein 
expression starting from 4 h of treatment in a time-dependent manner (Figure 3-3 D Left 
panels). This is mimicked by thapsigargin185, which induces ER stress via blocking ER Ca2+-
ATPase and disturbing ER Ca2+ homeostasis (Figure 3-3 D right panels). These data clearly 
suggest that progesterone may induce a HERG trafficking defect via promoting ER stress.  
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3.3.4 Role of protein kinases in the effect of progesterone on HERG K+ 
channels 
Progesterone regulates the expression and function of sodium and potassium ion channels via 
activation of protein kinases 113, 158. The role of protein kinases in the action of progesterone 
on HERG channels was therefore examined. As shown in Figure 3-4, the effect of 
progesterone on HERG trafficking was intact in the absence or presence of PD98059 (an 
ERK1/2-MAPK inhibitor), SB203580 (a p38-MAPK inhibitor), the JNK inhibitor, 
LY294002 (a PI3K inhibitor) or H-89 (a PKA inhibitor). We previously reported that cAMP 
may increase both mature and immature forms of HERG protein in HERG-HEK293 cells. 
We therefore examined whether cAMP can prevent the effect of progesterone. As shown in 
Figure 3-5, administration of a membrane permeable cAMP analog failed to prevent the 
progesterone-induced HERG K channel trafficking defect. These data suggest that the effect 
of progesterone is independent of the activation of these protein kinases.  
 
Figure 3-4. Effect of progesterone (5 µmol/L, 24 hours) on HERG channel maturation in the presence or 
absence of inhibitors of various protein kinases. PD98059 (20 µmol/L, ERK1/2 inhibitor), JNK inhibitor (20 
µmol/L), SB203580 (20 µmol/L, p38 inhibitor), H89 (100 nmol/L, PKA inhibitor), and LY294002 (20 µmol/L, 
AKT/PI3K inhibitor) failed to reverse the effect of progesterone. Mean±SEM. n=5. * p<0.05. 
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Figure 3-5. Effect of cAMP on HERG channel protein expression in the presence or absence of progesterone. 
(A) CPT-cAMP (5-500 µmol/L, 24 h) increased HERG protein (both immature and mature) abundance in a 
dose-dependent manner. Representative Western blots of 3 independent experiments. (B) CPT-cAMP (50 and 
150 µmol/L) failed to reverse the effect of progesterone (5µmol/L, 24 hours). Mean±SEM. n=4. * p<0.05.  
3.3.5 The effect of progesterone is neither progesterone receptor-mediated 
nor via de novo protein synthesis 
To examine whether the effect of progesterone is mediated by the nuclear progesterone 
receptor, RU486, a progesterone receptor antagonist, was used. RU486 decreased the mature 
form of HERG K+ channel slightly, but failed to block the inhibitory effect of progesterone 
on HERG maturation (Figure 3-6 A). These data suggest that the effect of progesterone is not 
mediated by the nuclear progesterone receptor. This is also supported by our functional data 
that progesterone decreased HERG K+ current density in CHO cells (Figure 3-2 C-E), which 
do not express progesterone receptors 186. As wide spectrum effects of progesterone are 
mediated by altering synthesis of proteins, we also examined whether the effect of 
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progesterone on HERG channels is secondary to de novo protein synthesis. Cycloheximide, a 
protein synthesis inhibitor, was employed. As shown in Figure 3-6 B, cycloheximide 
significantly decreased the total amount of HERG protein, but failed to prevent/abolish the 
effect of progesterone on HERG K+ channel maturation. These results indicate that the effect 
of progesterone on HERG channel trafficking is neither via stimulation of nuclear 
progesterone receptor nor via de novo protein synthesis.  
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Figure 3-6. Western blotting analysis showing the effect of progesterone (5 µmol/L, 24h) on HERG channel 
maturation at different situations in HERG-HEK293 cells. (A) The effect of progesterone was receptor 
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independent. RU486 (10 µmol/L) failed to reverse the effect of progesterone. (B) Effect of progesterone in the 
presence or absence of cycloheximide (CHX, 40 µmol/L). (C-D) The impaired HERG maturation was rescued 
by either treatment with 5 µmol/L E-4031 (C) or low temperature (27 ºC) incubation (D). Mean±SEM. n=4-5. * 
p<0.05,  n.s.: not significant.  
 
3.3.6 The effect of progesterone is reversed by a HERG channel blocker and 
low culture temperature  
Both E-4031, a HERG channel blocker, and low temperature (27 oC) improve the proper 
folding of HERG channel in ER 90. As shown in Figure 3-6 C-D, both maneuvers rescued the 
HERG channel trafficking-defect caused by progesterone. These data imply that 
progesterone may affect HERG channel folding in ER and/or block its trafficking to Golgi 
complex.  
3.3.7 Effect of progesterone on cholesterol level and distribution 
Protein folding/trafficking can be directly or indirectly affected by cholesterol 187-190. We first 
examined the role of cholesterol in the regulatory effect of progesterone on HERG K+ 
channel maturation. The free cholesterol in the cells was stained with filipin. As shown in Fig 
3-7 A, progesterone caused free cholesterol accumulation in the cytosol in a concentration-
dependent manner (1-5 µM). 2-hydroxypropyl-β-cyclodextrin (HPCD), a sterol-binding 
agent, redistributed cholesterol in the compartments of cells (Figure 3-7 B), which is 
consistent with previous reports 191-192.  
The effect of progesterone on cholesterol content was also examined. As shown in Figure 3-7 
C, progesterone had no significant effect, whereas simvastatin (10 µM, an inhibitor of de 
novo cholesterol synthesis) significantly decreased free and total cholesterol levels in HERG-
HEK293 cells. These data suggest that progesterone can only affect the distribution of 






















































Figure 3-7. Effect of progesterone on the distribution and level of cholesterol in HEK293 cells. (A-B) Filipin 
staining of intracellular free cholesterol.  (A) Progesterone induced accumulation of cholesterol in a dose-
dependent manner. (B) Sterol binding agent 2-hydroxypropyl-beta-cyclodextrin (HPCD, 10 mg/ml) abolished 
progesterone (5 µmol/L, 24 hours)-induced cholesterol accumulation. Photomicrographs were taken on an 
inverted microscope. This result represents three independent experiments. White scale bar represents 15 μm. 
(C) Cellular cholesterol levels were measured with Amplex®Red Cholesterol Assay. Cells were treated with 
simvastatin (10 µmol/L) or progesterone (5 µmol/L) for 24 hours. Mean±SEM. n=6. * p<0.05 vs the 




3.3.8 Progesterone blocks HERG channel trafficking via disturbing 
intracellular cholesterol homeostasis 
To investigate whether progesterone-induced accumulation of cholesterol is involved in the 
HERG trafficking defect, HER channel protein levels were determined in WT and mutant 
channels with and without HPCD treatment. Western blotting data showed that HPCD 
reversed the effect of progesterone on HERG channel maturation, but had no effect on that of 
V630A, a HERG trafficking mutant (Figure 3-8 A). These results suggest that intracellular 
cholesterol is involved in the mediation of WT HERG channel trafficking defect by 





























































































































Figure 3-8. Progesterone impaired HERG maturation via disrupting intracellular cholesterol homeostasis. (A) 
HPCD (10 mg/ml) rescued the HERG trafficking defect caused by progesterone (5 µmol/L, 24 hours), but not 
that caused by the V630A HERG mutant. n=4. (B) Over-expression of Rab9 partially rescued the 
progesterone(5 µmol/L, 24 hours)-induced HERG trafficking defect. n=6. (C) Effect of simvastatin (statin, 10 
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µmol/L), cholesterol (Chol, 20 µg/ml) or imipramine (Imip, 30 µmol/L) on HERG maturation. n=5. (D) HPCD 
(10 mg/ml) abolished the upregulated CHOP expression induced by progesterone (5 µmol/L), but not by 
thapsigargin (Thap, 200 nmol/L). The data represent three independent experiments. Mean±SEM. * p<0.05. n.s.: 
not significant. 
Rab9 GTPase is important for cholesterol trafficking and overexpression of Rab9 prevents 
cholesterol accumulation 193. We found in the present study that over-expression of Rab9, 
which itself had no effect on HERG trafficking, but partially reversed the HERG trafficking 
defect caused by progesterone (Figure 3-8 B). These data confirm that cholesterol 
accumulation is responsible for the progesterone-induced HERG trafficking defect.  
To confirm these findings, we decreased the cholesterol level with simvastatin, accumulated 
free cholesterol in the late endosome/lysosome with imipramine, or delivered a large amount 
of exogenous cholesterol into the cells. We found that all these treatments mimicked the 
effect of progesterone. In addition, simvastatin failed to reverse the effect of cholesterol 
(Figure 3-8 C). These data suggest that not only the cholesterol level, but also the distribution 
of free cholesterol, is important for HERG maturation. 
We further tested the involvement of cholesterol in progesterone-induced ER stress. As 
shown in Figure 3-8 D, HPCD reversed progesterone-induced up-regulation of CHOP 
expression, but failed to affect thapsigargin-induced CHOP expression. These data further 
indicate that progesterone may impair HERG maturation by disturbing intracellular 
cholesterol homeostasis and the subsequent ER stress. 
3.3.9 The specificity of progesterone on HERG K+ channel trafficking 
In this series of experiments, we first studied whether progesterone has a similar effect on L-
type CaV1.2 calcium channels. The human cardiac CaV1.2CM184, and its accessory subunits, 
β2a and α2δ, were transfected into HEK 293 cells. Two protocols, IV protocol (Figure 3-9 A) 
and tail protocol (Figure 3-7B), were employed to record IBa  carried by Ba2+ through the 
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CaV1.2CM channels. As shown in the right panels of Figure 3-9 A-B, the current densities 
recorded with the two protocols were not affected by progesterone (5 µM, 24 h). The effect 






















































































Figure 3-9. Effects of progesterone (5 µmol/L, 24 h) on currents of Voltage-gated L-type Ca2+ channels, 
endogenous K+ channels and trafficking of Kv1.5 channels. (A-B) Effect of progesterone on L-type Ca2+ current 
density. (A) Current-voltage (I-V) relation curve plotted from peak currents at different voltages. Cells were 
activated from the holding potential (-100 mV) via a series of depolarizing pulses (-60 to 40 mV) for 900 ms. 
n=9-12. (B) I-V curve plotted from the peak tail currents. Cells were activated via a series of depolarizing 
pulses (-60 to 100 mV) for 20 ms, and the tail currents were recorded at the voltage of -50 mV. n=7-12. (C) 
Effect of progesterone on endogenous voltage-gated K+ currents of HEK293 cells. I-V relation curve plotted 
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from the currents measured at the end of depolarizing test pulses. Cells were activated from the holding 
potential (-70 mV) via a series of depolarizing pulses (-60 to 120 mV) for 5 s. n=9. (D) Effect of progesterone 
on the trafficking of Kv1.5 and HERG. Both myc-Kv1.5 and myc-HERG were transiently transfected into 
HEK293 cells. Cells were treated with progesterone or vehicle for 24 h. Anti-myc antibody was used to detect 
both myc-Kv1.5 and myc-HERG. For these two potassium channels, the upper bands (arrows) indicate the 
mature or fully-glycosylated form, and the lower bands (arrowheads) indicate the immature or core-
glycosylated form. Mean±SEM. n=5. * p<0.05. 
in Figure 3-9 C, progesterone had no significant effect on current density of endogenous IKv.  
Kv1.5 channel undergoes similar glycosylation and trafficking to HERG. The fully-
glycosylated form (75 kDa) mainly represents the plasma membrane channel, whereas the 
core-glycosylated form (68KDa) mainly represents the immature form in ER 194. As shown in 
Figure 3-9 D, treatment with progesterone (5 µM) for 24 h only impaired the trafficking of 
HERG, but had no effect on that of Kv1.5 K+ channels. Taken together, these results 
demonstrate that progesterone specifically induces the trafficking defect of HERG K+ 
channel, but not CaV1.2 channels and Kv1.5 K+ channels. 
3.3.10 Progesterone impaired the maturation of ERG K+ channels in rat 
neonatal cardiac myocytes 
To test whether progesterone affects ERG K+ channels in the native cells, rat neonatal cardiac 
myocytes were isolated and cultured with progesterone. As shown in Figure 3-10, there are 
two forms of ERG protein (160 KDa and 120 KDa), which are consistent with the mature 
and immature forms of rat ERG1a as previously reported 155. We found that treatment with 
progesterone (5 µM) for 24 h significantly decreased the mature form of the ERG K+ channel, 
suggesting that progesterone may also impair the maturation of ERG channels in the native 




Figure 3-10. Effect of progesterone on ERG protein expression (A) and currents (B) in rat neonatal cardiac 
myocytes. One day after isolation, rat neonatal cardiac myocytes were treated with progesterone (5 µmol/L, 24 
h). (A) Western blots showing protein expression. The upper band (arrow pointed, around 160 kD) is the mature 
form of the ERG channel, whereas the lower band (arrowhead, around 130 kDa) is the immature form. 
Mean±SEM. n=8. * p<0.05. (B) ERG/IKr recording. (a) Representative current tracings recorded from rat 
neonatal cardiac myocyte. Inserts show the recording protocol and current and time scales. (b) Enlarged tracings 
of the indicated box in (a) to show that rat ERG currents were suppressed by progesterone (5 µmol/L, 24 h); (c) 
Voltage-dependent activation curves plotted from peak tail currents during a repolarizing step to -40 mV after 
depolarizing to various voltages. ■,control, n=26; ●, progesterone treatment, n=17. Mean±SEM. * p<0.05. 
3.4 Discussion 
HERG trafficking defects are one of the main causes of long QT syndrome (LQTS). 
Trafficking can be impaired by mutations of the channel 27 or induced by drugs such as 
probucol, cardiac glycosides, fluoxetine, norfluoxetine, pentamidine, arsenic trioxide and 
celastrol 96, 194. We report here that a HERG trafficking defect can also be induced by 
excessive progesterone hormone. The impaired HERG trafficking may, in turn, induce 
imbalance of heart electrical stability and therefore development of ventricular arrhythmias. 
This may suggest a mechanism to explain why the corrected QT intervals are longer in 
pregnancy and why women at late pregnancy are more susceptible to ventricular arrhythmias. 
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Since progesterone may not be able to further impair the defective trafficking of the mutated 
HERG channels in the inherited LQTS patients, our findings may also explain why the 
incidence of arrhythmias is not higher in pregnancy than in other periods in the life of these 
patients 165, 175.  
During the late phase of pregnancy, the progesterone level in fetal circulation (~4.5 µmol/L) 
is much higher than that in maternal blood (1 µmol/L). This may imply that progesterone has 
greater impact on the fetal heart and could explain the higher rate of sudden death in the 
uterus than at most other times in the human life cycle.  
Apart from the Western blots and patch clamp data, the impaired HERG protein trafficking 
by progesterone was further confirmed with confocal microscopy. Progesterone 
preferentially decreased membrane protein expression. More importantly, progesterone 
treatment induced ER stress and dilation. Immature HERG protein may be stuck in the 
dilated ER. This may prevent the maturation and trafficking of HERG into Golgi and plasma 
membrane. 
 To investigate the mechanism, we first examined whether the effect of progesterone is 
mediated by nuclear progesterone receptors. We found that RU486, a progesterone receptor 
blocker, failed to reverse the effect of progesterone on HERG K+ channel trafficking. In 
addition, the inhibitory effect of progesterone on HERG currents in CHO cells, a cell line 
without expression of progesterone receptor 186, further supports the hypothesis that the effect 
of progesterone is nuclear receptor-independent.  In addition, progesterone did not decrease 
the total amount of HERG protein. Cycloheximide, a protein synthesis inhibitor, decreased 
total protein expression but failed to block the progesterone effect. These results indicate that 
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the effect of progesterone is not via altering protein synthesis. The role of protein kinases was 
also investigated and we found that the effect of progesterone is not secondary to activation 
of MAPK, PI3K/Akt, cAMP or PKA.  
Cholesterol homeostasis is very important for protein folding and trafficking. Cholesterol 
may affect membrane protein folding either directly or indirectly. For example, nicotinic 
acetycholine receptor (nAChR) contains internal binding sites for cholesterol and cholesterol 
binding stabilizes nAChR protein structure. Overloading of free cholesterol may also directly 
cause ER stress and ER dilation 195 and therefore impairs protein folding. We therefore 
examined whether the progesterone-induced HERG trafficking defect involves cholesterol. 
We found in the present study that progesterone induced intracellular free cholesterol 
accumulation, which further induces ER stress and ER dilation. Since progesterone can insert 
into lipid bilayers and perturb membrane function and lipid mobility 196, direct interaction 
between progesterone and lipids may be responsible for the action of progesterone on 
intracellular cholesterol homeostasis.  HPCD is a sterol-binding agent, which redistributes 
cholesterol in the cellular compartments. HPCD also can disrupt membrane lipid rafts and 
affect functions of membrane receptors, ion channels, transporters, protein kinases 
located/related with lipid rafts. We found that HPCD abolished the effect of progesterone on 
cholesterol homeostasis, ER stress and HERG trafficking. Rab9 is important for cholesterol 
trafficking. Overexpression of Rab9 prevents cholesterol accumulation. We found in this 
study that Rab9 also reversed HERG trafficking defects. These data confirm that the 
progesterone-induced HERG trafficking defect is secondary to the accumulation of 
cholesterol. In addition, disrupting intracellular cholesterol homeostasis with simvastatin, 
imipramine or exogenous delivery of cholesterol mimicked the effect of progesterone on 
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HERG K+ channel trafficking. Thus, impaired cholesterol processing (either high levels, low 
levels or disrupted distribution) may contribute to HERG K+ channel defects caused by 
progesterone.  
The mechanisms underlying cholesterol-induced ER stress are still not clear. It has been 
reported that free cholesterol accumulation in the ER membrane activates the unfolded 
protein response (UPR) 197. The UPR may induce ER-phagy, which selectively sequesters 
and tightly packs ER membranes into autophagosomes 198. In ER, cholesterol is also an 
important factor for ER-Golgi membrane transport. Sterol depletion in the ER inhibits the 
ER-to-Golgi transport of secretory cargo membrane protein ts-O45-G, vesicular stomatitis 
virus glycoprotein and scavenger receptor A 187-188. In addition, inhibition of the early stage 
of de novo cholesterol synthesis can also affect isoprenoid intermediates, which are very 
important for the membrane anchoring and activation of small G proteins such as Ras, Rho 
and Rab.  The dysfunction of these G proteins can affect protein trafficking 189-190. More 
studies are warranted to examine how exactly cholesterol regulates ER function and ER 
stress.  
In summary, progesterone may disturb intracellular cholesterol homeostasis and block 
HERG channel trafficking, which may prolong the QT intervals of both mother and fetus and 
increase the risk of developing ventricular arrhythmias.  Our study may reveal a new 
mechanism for pregnancy-associated LQTS and provide new approaches to prevent 
ventricular arrhythmias and sudden death. 
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Chapter4 GENERAL DISCUSSION AND CONCLUSION 
4.1 General discussion 
Female gender is a risk factor for drug-induced cardiac arrhythmia110, with an approximately 
2:1 preponderance of women to men developing torsade de pointes (TdP) arrhythmias in 
response to similar concentrations of a wide variety of drugs 120. The international LQTS 
registry reported that females had high risk of encountering first cardiac event between age 
15 and 40 compared with the males at the same age199.  
Several lines of evidence indicate that androgen plays important roles in this gender 
difference in arrhythmia. Clinical studies indicate that the gender difference in QTc intervals 
can only be observed after puberty122. Adult men have high androgen level (testosterone: 
16.8±6.1 nmol/L; 5α-DHT: 1.5±0.8 nmol/L)119, shorter QTc intervals122, 200 and lower 
incidence of cardiac event200. In contrast, adult women have lower androgen level 
(testosterone: 0.6-2.5 nmol/L; 5α-DHT: ~0.02 nmol/L)118, longer QTc intervals122 and high 
frequent occurrence of self-terminating TdP199. In addition, cardiac repolarization periods in 
castrated men and normal women are longer than those in normal men and women with 
virilization who have higher androgen concentration124. Moreover, testosterone replacement 
therapy restores male ECG patterns of repolarization in the castrated men124. This is also 
supported by animal experiments which show that androgen replacement treatment also 
restores the prolonged QT intervals in orchiectomized male rabbits 116. All these experiments 
suggest that androgen, but not estrogen, is responsible for the different QT intervals and 
incidence sof cardiac events between men and women. 
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Among cardiac ion currents, HERG K+ channel current/Ikr is critic for the repolarization of 
cardiac myocytes. Malfunction of HERG K+ channel is one of main causes for LQTS.  
Several findings indicate that the HERG K+ channel current/Ikr can be the target of androgen 
and this modulation may be a potential underlying mechanism for the gender difference in 
arrhythmia. Rabbit is a good animal model for studying the gender difference in LQTS, as 
this difference can be observed in rabbit as human beings. In rabbit, it was found that  Ikr 
density is high in male cardiac myocytes than in female117. Androgen treatment increases Ikr 
density with no changes on HERG mRNA level116. However, the molecular mechanism of 
this modulation is unclear yet. 
One of the aims of this study is therefore to investigate the underlying mechanism of 
androgen modulation on HERG K+ channel/ Ikr.  The unexpected result is that N-terminal 
truncated variant androgen receptor (AR45) but not the full length androgen receptor (AR) is 
involved in the androgen induced HERG channel protein augmentation. In the heart, the 
expression level of AR45 is much higher than AR. AR45 has very weak or no transactivation 
efficiency compared with AR, partially because AR45 lacks activation function-1 domain. In 
this study, we found that the stimulation of AR45 didn’t affect the transcription level of 
HERG channel, which is consistent with previous study that androgen treatment increased Ikr 
without changes on HERG mRNA level. My further studies indicate that the stimulation of 
AR45 can stabilize HERG protein. This is a new mechanism for the modulation of HERG 
channel protein. Taken together, the stabilization of HERG channel proteins can be 
modulated by HERG gene mutation82, 107, HERG protein glycosylation91, ceramide106, 
extracellular potassium ion28, 107, 109 and androgens (this work).  
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My study also shows that estrogen and progesterone (for non-pregnancy state) do not change 
HERG channel protein level. For the acute effect, sex hormones (androgen, estrogen and 
progesterone) have weak or no effect on HERG channel function 112-113, 201.   Taken together, 
androgen but not estrogen and progesterone, stabilizes HERG channel protein via stimulation 
of AR45, which may contribute to the gender difference in LQTS. 
Other cardiac ion currents may also be modulated by sex hormones and the modulations may 
affect cardiac repolarization. Furukawa and his colleagues reported that acute treatment with 
sex hormones potentiated Iks and inhibited ICa,L112-113, 201.  The mechanistic studies show that 
acute treatment with all these three sex hormones can potentiate Iks via different mechanisms. 
While androgen or progesterone can potentiate Iks and attenuate ICa,L via AKT/NOS signaling 
pathway112-113. Estrogen potentiated Iks via estrogen receptor201. However, as all these sex 
hormones have similar effect on Iks and ICa,L, this modulation may not contribute to gender 
difference in LQTS.  
Compared with androgen and estrogen whose levels are relatively low (nmol/L) at 
physiological situation, progesterone can reach very high concentration (µmol/L) in 
pregnancy and plays some unique roles in human life. Progesterone level may increase from 
0.6-4.5 nmol/L during the preovulatory phase to 10.5-80 nmol/L during the luteal phase163, 
which is important for embryo implantation. During the pregnancy, progesterone level 
increases steadily and may reach 1 μmol/L in mother’s blood and 5 μmol/L in embryo before 
the delivery168. This high concentration of progesterone is important for maintaining 
conducive environment for embryo.  
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However, my study indicates that the very high level of progesterone may be harmful for the 
embryo as it blocked HERG channel trafficking. HERG channel not only plays important 
roles in adult but also in the embryo. Malfunctions of HERG channel in the embryo not only 
induce fetal LQTS, but also induce hypoxia in the embryo, which in turn affect the normal 
development182. It was found that super high progesterone level in embryo is related with 
high chance of emergency cesarean section168. The authors suggested that the hypoxia 
environment for the embryo may stimulate progesterone secretion. My study indicates that 
the increased progesterone may disrupt HERG K+ channel trafficking and affect heart 
function, which may worsen the hypoxia situation. 
In the present study, the data from western blot, immunostaining and patch clamp recording 
suggest that chronic progesterone treatment inhibited HERG K+ channel trafficking. The 
defect of HERG K+ channel trafficking can be rescued by lower temperature incubation or 
specific HERG K+ channel blocker. These data suggested that progesterone may impair 
HERG K+ channel folding as lower temperature can prolong the folding process and 
facilitate HERG K+ channel proper folding and channel blocker can bind the pore region of 
the channel and stabilize channel conformation. The confocal images show that progesterone 
treatment blocked HERG K+ channel trafficking and accumulated HERG K+ channels in the 
dilated ER.  As there were changes on the ER morphology, we tested whether progesterone 
treatment induced ER stress with a hall marker CHOP. Progesterone increased CHOP 
expression in a time-dependent manner which indicates progesterone treatment can induce 
ER stress. 
As a steroid hormone, progesterone has a variety of targets in the cells. The classical one is 
the nuclear progesterone receptors, which can trigger a set of gene transcription up on the 
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progesterone treatment. However, the data from progesterone receptor negative cells and 
progesterone receptor inhibitor suggested that progesterone impaired HERG K+ channel 
trafficking without the involvement of nuclear progesterone receptor. Progesterone may 
activate numerous protein kinases and impair HERG K+ channel trafficking. In this study, we 
employed pharmacological tools to examine the involvement of protein kinases, and found 
all of the protein kinase inhibitors used here failed to block progesterone induced HERG K+ 
channel trafficking.  
Progesterone can also impair intracellular cholesterol homeostasis by affecting cholesterol 
trafficking, esterification and biosynthesis160-162. In this study, I found that progesterone 
changed intracellular cholesterol distribution in a dose-dependent manner. Sterol binding 
reagent HPCD redistributed intracellular cholesterol, attenuated progesterone induced ER 
stress and HERG K+ channel trafficking defect. Intracellular cholesterol trafficking can be 
facilitated by small GTPase as Rab9193. In this study, transfection with Rab9 attenuated the 
effect of progesterone on HERG K+ channel trafficking. In addition, the defect of  HERG K+ 
channel trafficking was mimicked by impairing intracellular cholesterol homeostasis as 
decreasing the cholesterol level with simvastatin, accumulating free cholesterol in the late 
endosome/lysosome with imipramine, or delivering a large amount of exogenous cholesterol 
into the cells. Taken together, these data indicate that the progesterone impaired intracellular 
cholesterol homeostasis, induced ER stress and defected HERG K+ channel trafficking. 
4.2 Conclusion and Perspectives 
This thesis examined how sex hormones regulate HERG K+ channels with a combination of 
pharmacological manipulations, confocal microscopy, molecular biology and electrical 
physiology. The data presented in this thesis demonstrate for the first time that (i) the 
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stimulation of AR45 by androgen can stabilize HERG K+ channel protein via ERK1/2 
signaling pathway; (ii) progesterone impairs HERG K+ channel protein trafficking via 
disturbing intracellular cholesterol homeostasis; (iii) chronic estrogen treatment have no 
effect on HERG K+ channel protein level. This study not only provides a molecular 
mechanism for the sex differences in QT intervals and drug-induced arrhythmias but also 
explains the longer QT interval during late pregnancy and the high risk of arrhythmias 
development in the fetus 
In general, the significant contribution of this thesis may include that: 
• prolonged androgen treatment stabilizes HERG channel protein. These findings may 
provide an important mechanism for gender difference of Long QT Syndrome. 
• cardiac isoform AR45, but not full length AR, is responsible for the effect of 
androgen on HERG channel proteins. These data indicate that different androgen 
receptor isoforms may play different physiological roles. 
• prolonged progesterone treatment blocks HERG channel protein trafficking. These 
findings may explain why QT interval is prolonged and why the incidence of cardiac 
events is higher during the late pregnancy.  
• disruption of intracellular cholesterol may block HERG channel protein trafficking. 
This may open up a new area for unveiling cholesterol related arrhythmia.   
Although the full length of HERG protein is the dormant and functional subunit for Ikr, it will 
be interesting to study the effect of sex hormones on two splice variants of HERG protein, N-
terminal splice variant (HERG1b)155, 202 and C-terminal splice variant (HERGUSO)203, which 
were discovered recently. Both HERG1b and HERGUSO can be detected in the heart and can 
modulate HERG current kinetics when co-expressed in heterological expression system204 203.  
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In addition, due to the time limitation, only the ERG protein expression was examine in the 
native cardiac myocytes. Further studies on ERG current and other cardiac ion currents in the 
native cardiac myocytes are needed for better understanding the modulation of sex hormones 
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